false2024Q10000883237--12-31P1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purevrts:collateralized_loan_obligation00008832372024-01-012024-03-3100008832372024-05-010000883237vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember2024-03-310000883237vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember2023-12-3100008832372024-03-3100008832372023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2023-12-310000883237vrts:InvestmentManagementFeesMember2024-01-012024-03-310000883237vrts:InvestmentManagementFeesMember2023-01-012023-03-310000883237vrts:DistributionAndServiceFeesMember2024-01-012024-03-310000883237vrts:DistributionAndServiceFeesMember2023-01-012023-03-310000883237vrts:AdministrationAndShareholderServiceFeesMember2024-01-012024-03-310000883237vrts:AdministrationAndShareholderServiceFeesMember2023-01-012023-03-310000883237vrts:OtherIncomeAndfeesMember2024-01-012024-03-310000883237vrts:OtherIncomeAndfeesMember2023-01-012023-03-3100008832372023-01-012023-03-310000883237vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember2024-01-012024-03-310000883237vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember2023-01-012023-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2024-01-012024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2023-01-012023-03-3100008832372022-12-3100008832372023-03-310000883237us-gaap:CommonStockMember2022-12-310000883237us-gaap:AdditionalPaidInCapitalMember2022-12-310000883237us-gaap:RetainedEarningsMember2022-12-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000883237us-gaap:TreasuryStockCommonMember2022-12-310000883237us-gaap:ParentMember2022-12-310000883237us-gaap:NoncontrollingInterestMember2022-12-310000883237us-gaap:RetainedEarningsMember2023-01-012023-03-310000883237us-gaap:ParentMember2023-01-012023-03-310000883237us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000883237us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000883237us-gaap:CommonStockMember2023-01-012023-03-310000883237us-gaap:CommonStockMember2023-03-310000883237us-gaap:AdditionalPaidInCapitalMember2023-03-310000883237us-gaap:RetainedEarningsMember2023-03-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000883237us-gaap:TreasuryStockCommonMember2023-03-310000883237us-gaap:ParentMember2023-03-310000883237us-gaap:NoncontrollingInterestMember2023-03-310000883237us-gaap:CommonStockMember2023-12-310000883237us-gaap:AdditionalPaidInCapitalMember2023-12-310000883237us-gaap:RetainedEarningsMember2023-12-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000883237us-gaap:TreasuryStockCommonMember2023-12-310000883237us-gaap:ParentMember2023-12-310000883237us-gaap:NoncontrollingInterestMember2023-12-310000883237us-gaap:RetainedEarningsMember2024-01-012024-03-310000883237us-gaap:ParentMember2024-01-012024-03-310000883237us-gaap:NoncontrollingInterestMember2024-01-012024-03-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000883237us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000883237us-gaap:CommonStockMember2024-01-012024-03-310000883237us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000883237us-gaap:CommonStockMember2024-03-310000883237us-gaap:AdditionalPaidInCapitalMember2024-03-310000883237us-gaap:RetainedEarningsMember2024-03-310000883237us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000883237us-gaap:TreasuryStockCommonMember2024-03-310000883237us-gaap:ParentMember2024-03-310000883237us-gaap:NoncontrollingInterestMember2024-03-310000883237vrts:OpenEndFundsMember2024-01-012024-03-310000883237vrts:OpenEndFundsMember2023-01-012023-03-310000883237vrts:ClosedEndFundsMember2024-01-012024-03-310000883237vrts:ClosedEndFundsMember2023-01-012023-03-310000883237vrts:RetailSeparateAccountsMember2024-01-012024-03-310000883237vrts:RetailSeparateAccountsMember2023-01-012023-03-310000883237vrts:InstitutionalAccountsMember2024-01-012024-03-310000883237vrts:InstitutionalAccountsMember2023-01-012023-03-310000883237vrts:AlphaSimplexGroupLLCMember2023-04-012023-04-010000883237vrts:AlphaSimplexGroupLLCMember2023-04-010000883237srt:ParentCompanyMember2024-03-310000883237srt:ParentCompanyMember2023-12-310000883237vrts:SponsoredFundsMember2024-03-310000883237vrts:SponsoredFundsMember2023-12-310000883237us-gaap:EquitySecuritiesMember2024-03-310000883237us-gaap:EquitySecuritiesMember2023-12-310000883237us-gaap:FairValueInputsLevel1Member2024-03-310000883237us-gaap:FairValueInputsLevel2Member2024-03-310000883237us-gaap:FairValueInputsLevel3Member2024-03-310000883237us-gaap:FairValueInputsLevel1Membervrts:SponsoredFundsMember2024-03-310000883237vrts:SponsoredFundsMemberus-gaap:FairValueInputsLevel2Member2024-03-310000883237us-gaap:FairValueInputsLevel3Membervrts:SponsoredFundsMember2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310000883237us-gaap:FairValueInputsLevel1Membervrts:NonqualifiedRetirementPlanAssetsMember2024-03-310000883237us-gaap:FairValueInputsLevel2Membervrts:NonqualifiedRetirementPlanAssetsMember2024-03-310000883237us-gaap:FairValueInputsLevel3Membervrts:NonqualifiedRetirementPlanAssetsMember2024-03-310000883237vrts:NonqualifiedRetirementPlanAssetsMember2024-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel1Member2024-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel2Member2024-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2024-03-310000883237vrts:ContingentConsiderationLiabilityMember2024-03-310000883237us-gaap:FairValueInputsLevel1Member2023-12-310000883237us-gaap:FairValueInputsLevel2Member2023-12-310000883237us-gaap:FairValueInputsLevel3Member2023-12-310000883237us-gaap:FairValueInputsLevel1Membervrts:SponsoredFundsMember2023-12-310000883237vrts:SponsoredFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310000883237us-gaap:FairValueInputsLevel3Membervrts:SponsoredFundsMember2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310000883237us-gaap:FairValueInputsLevel1Membervrts:NonqualifiedRetirementPlanAssetsMember2023-12-310000883237us-gaap:FairValueInputsLevel2Membervrts:NonqualifiedRetirementPlanAssetsMember2023-12-310000883237us-gaap:FairValueInputsLevel3Membervrts:NonqualifiedRetirementPlanAssetsMember2023-12-310000883237vrts:NonqualifiedRetirementPlanAssetsMember2023-12-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel1Member2023-12-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel2Member2023-12-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310000883237vrts:ContingentConsiderationLiabilityMember2023-12-310000883237vrts:WestchesterCapitalManagementMemberus-gaap:FairValueInputsLevel3Member2024-03-310000883237srt:MinimumMembervrts:WestchesterCapitalManagementMemberus-gaap:MeasurementInputDiscountRateMember2024-03-310000883237vrts:WestchesterCapitalManagementMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-03-310000883237vrts:WestchesterCapitalManagementMemberus-gaap:MeasurementInputComparabilityAdjustmentMember2024-03-310000883237us-gaap:FairValueInputsLevel3Membervrts:NFJInvestmentGroupMember2024-03-310000883237srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMembervrts:NFJInvestmentGroupMember2024-03-310000883237srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMembervrts:NFJInvestmentGroupMember2024-03-310000883237us-gaap:MeasurementInputComparabilityAdjustmentMembervrts:NFJInvestmentGroupMember2024-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-12-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310000883237vrts:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-03-3100008832372024-02-212024-02-210000883237us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000883237us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000883237us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000883237us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000883237us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000883237us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000883237us-gaap:CommonStockMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000883237srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000883237srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000883237us-gaap:RestrictedStockUnitsRSUMember2023-12-310000883237us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000883237us-gaap:RestrictedStockUnitsRSUMember2024-03-310000883237us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310000883237vrts:RestrictedStockUnitsRSUsPerformanceBasedMember2024-01-012024-03-310000883237vrts:RestrictedStockUnitsRSUsPerformanceBasedMember2023-01-012023-03-310000883237vrts:PerformanceStockUnitsIncentiveMember2024-01-012024-03-310000883237vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember2024-03-310000883237vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember2024-01-012024-03-310000883237us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000883237us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310000883237vrts:TermLoanMembervrts:CreditAgreementMember2021-09-280000883237vrts:TermLoanMembervrts:CreditAgreementMember2021-09-282021-09-280000883237us-gaap:RevolvingCreditFacilityMembervrts:CreditAgreementMember2021-09-280000883237us-gaap:RevolvingCreditFacilityMembervrts:CreditAgreementMember2021-09-282021-09-280000883237vrts:TermLoanMemberus-gaap:SecuredDebtMember2024-01-012024-03-310000883237vrts:TermLoanMemberus-gaap:SecuredDebtMember2024-03-310000883237vrts:TermLoanMembervrts:CreditFacility2017Member2024-03-310000883237srt:AffiliatedEntityMember2023-12-310000883237srt:AffiliatedEntityMember2024-01-012024-03-310000883237us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMembervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2024-01-012024-03-310000883237srt:AffiliatedEntityMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2024-01-012024-03-310000883237us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2024-01-012024-03-310000883237srt:AffiliatedEntityMember2024-03-310000883237vrts:VotingInterestEntityVOEMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember2024-03-310000883237vrts:VotingInterestEntityVOEMember2023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember2023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember2023-12-310000883237vrts:SubordinatedNotesNewfleetCLO20161Membervrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember2024-03-310000883237vrts:SeniorSecuredFloatingRateNotesNewfleetCLO20161Memberus-gaap:SeniorNotesMembervrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember2024-03-310000883237vrts:SubordinatedNotesNewfleetCLO20161Membervrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMemberus-gaap:SubordinatedDebtMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember2024-01-012024-03-310000883237us-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:FairValueMeasurementsRecurringMembervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2024-03-310000883237us-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2024-03-310000883237us-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2024-03-310000883237us-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:EquitySecuritiesMembervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000883237us-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:FairValueMeasurementsRecurringMembervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember2023-12-310000883237us-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2023-12-310000883237us-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2023-12-310000883237us-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Membervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237us-gaap:EquitySecuritiesMembervrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2023-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2022-12-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2024-01-012024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2023-01-012023-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2024-03-310000883237vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMemberus-gaap:DebtSecuritiesMember2023-03-310000883237us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-10994  
vrtslogo2019a02.jpg
VIRTUS INVESTMENT PARTNERS, INC.
(Exact name of registrant as specified in its charter)
Delaware 26-3962811
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)
One Financial Plaza, Hartford, CT 06103
(Address of principal executive offices, including Zip Code)
(800) 248-7971
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value VRTSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒ No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
 
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  ☒
The number of shares outstanding of the registrant’s common stock was 7,127,881 as of May 1, 2024.










VIRTUS INVESTMENT PARTNERS, INC.
INDEX
 
  Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.
"We," "us," "our," the "Company," and "Virtus" as used in this Quarterly Report on Form 10-Q (the "10-Q") refer to Virtus Investment Partners, Inc., a Delaware corporation, and its subsidiaries.



PART I – FINANCIAL INFORMATION
 
Item 1.    Financial Statements
Virtus Investment Partners, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)March 31,
2024
December 31,
2023
Assets:
Cash and cash equivalents$123,880 $239,602 
Investments127,448 132,696 
Accounts receivable, net116,387 109,076 
Assets of consolidated investment products ("CIP")
Cash and cash equivalents of CIP123,030 100,732 
Cash pledged or on deposit of CIP767 680 
Investments of CIP2,081,225 2,082,713 
Other assets of CIP31,848 43,235 
Furniture, equipment and leasehold improvements, net26,088 26,216 
Intangible assets, net416,784 432,119 
Goodwill397,098 397,098 
Deferred taxes, net23,974 25,024 
Other assets79,596 89,438 
Total assets$3,548,125 $3,678,629 
Liabilities and Equity
Liabilities:
Accrued compensation and benefits$95,591 $200,837 
Accounts payable and accrued liabilities44,282 38,756 
Dividends payable16,553 17,291 
Contingent consideration 66,704 90,938 
Debt253,008 253,412 
Other liabilities67,460 91,471 
Liabilities of CIP
Notes payable of CIP1,922,051 1,922,243 
Securities purchased payable and other liabilities of CIP91,288 90,523 
Total liabilities2,556,937 2,705,471 
Commitments and Contingencies (Note 14)
Redeemable noncontrolling interests115,185 104,869 
Equity:
Equity attributable to Virtus Investment Partners, Inc.:
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,224,489 shares issued and 7,127,881 shares outstanding at March 31, 2024; and 12,163,228 shares issued and 7,087,728 shares outstanding at December 31, 2023
122 122 
Additional paid-in capital1,298,157 1,300,999 
Retained earnings (accumulated deficit)223,023 207,356 
Accumulated other comprehensive income (loss)(187)(87)
Treasury stock, at cost, 5,096,608 and 5,075,500 shares at March 31, 2024 and December 31, 2023, respectively
(649,463)(644,464)
Total equity attributable to Virtus Investment Partners, Inc.871,652 863,926 
Noncontrolling interests4,351 4,363 
Total equity 876,003 868,289 
Total liabilities and equity$3,548,125 $3,678,629 

The accompanying notes are an integral part of these condensed consolidated financial statements.
1

Virtus Investment Partners, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
Three Months Ended
March 31,
(in thousands, except per share data)20242023
Revenues
Investment management fees$188,360 $164,478 
Distribution and service fees14,030 14,153 
Administration and shareholder service fees18,678 18,359 
Other income and fees974 884 
Total revenues222,042 197,874 
Operating Expenses
Employment expenses115,163 98,614 
Distribution and other asset-based expenses24,348 23,715 
Other operating expenses31,375 30,730 
Other operating expenses of consolidated investment products ("CIP")690 700 
Restructuring expense797  
Depreciation expense2,028 1,145 
Amortization expense15,335 14,391 
Total operating expenses189,736 169,295 
Operating Income (Loss)32,306 28,579 
Other Income (Expense)
Realized and unrealized gain (loss) on investments, net3,416 2,670 
Realized and unrealized gain (loss) of CIP, net1,535 2,596 
Other income (expense), net550 (343)
Total other income (expense), net5,501 4,923 
Interest Income (Expense)
Interest expense(5,681)(5,005)
Interest and dividend income3,469 3,238 
Interest and dividend income of investments of CIP51,115 46,814 
Interest expense of CIP(40,012)(35,203)
Total interest income (expense), net8,891 9,844 
Income (Loss) Before Income Taxes46,698 43,346 
Income tax expense (benefit)8,831 8,703 
Net Income (Loss)37,867 34,643 
Noncontrolling interests(8,009)3,981 
Net Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,858 $38,624 
Earnings (Loss) per Share—Basic$4.19 $5.33 
Earnings (Loss) per Share—Diluted$4.10 $5.21 
Weighted Average Shares Outstanding—Basic7,119 7,245 
Weighted Average Shares Outstanding—Diluted7,287 7,410 

The accompanying notes are an integral part of these condensed consolidated financial statements.
2

Virtus Investment Partners, Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
 
 Three Months Ended
March 31,
(in thousands)20242023
Net Income (Loss)$37,867 $34,643 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively
(100)99 
Other comprehensive income (loss)(100)99 
Comprehensive income (loss)37,767 34,742 
Comprehensive (income) loss attributable to noncontrolling interests(8,009)3,981 
Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,758 $38,723 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3

Virtus Investment Partners, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

 Three Months Ended
March 31,
(in thousands)20242023
Cash Flows from Operating Activities:
Net income (loss)$37,867 $34,643 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation expense, intangible asset and other amortization18,164 16,410 
Stock-based compensation6,831 5,749 
Equity in earnings of equity method investments(498)554 
Realized and unrealized (gains) losses on investments, net(3,393)(2,670)
Deferred taxes, net1,086 1,441 
Changes in operating assets and liabilities:
Sales (purchases) of investments, net5,987 5,217 
Accounts receivable, net and other assets(341)8,725 
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities(120,631)(115,514)
Operating activities of consolidated investment products ("CIP"):
Realized and unrealized (gains) losses on investments of CIP, net(3,732)(3,844)
Purchases of investments by CIP(304,516)(320,808)
Sales of investments by CIP323,720 323,380 
Net proceeds (purchases) of short-term investments and securities sold short by CIP206 (218)
Change in other assets and liabilities of CIP4,722 3,976 
Net cash provided by (used in) operating activities(34,528)(42,959)
Cash Flows from Investing Activities:
Capital expenditures(1,923)(1,448)
Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net(537)(52)
Purchase of equity method investment (11,645)
Net cash provided by (used in) investing activities(2,460)(13,145)
Cash Flows from Financing Activities:
Repayments on credit agreement(688)(688)
Common stock dividends paid(14,929)(14,083)
Repurchase of common shares(5,000) 
Payment of contingent consideration(24,234)(27,179)
Taxes paid related to net share settlement of restricted stock units(9,854)(12,209)
Affiliate equity sales (purchases)(419) 
Net contributions from (distributions to) noncontrolling interests16,772 294 
Financing activities of CIP:
Payments on borrowings by CIP(17,794)(61,213)
Net cash provided by (used in) financing activities(56,146)(115,078)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(203)180 
Net increase (decrease) in cash, cash equivalents and restricted cash(93,337)(171,002)
Cash, cash equivalents and restricted cash, beginning of period341,014 589,179 
Cash, cash equivalents and restricted cash, end of period$247,677 $418,177 
Non-Cash Financing Activities:
Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net$(13,624)$(3,447)
Common stock dividends payable$13,467 $11,850 

(in thousands)March 31,
2024
December 31, 2023
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents$123,880 $239,602 
Cash of CIP123,030 100,732 
Cash pledged or on deposit of CIP767 680 
Cash, cash equivalents and restricted cash at end of period$247,677 $341,014 



The accompanying notes are an integral part of these condensed consolidated financial statements.
4

Virtus Investment Partners, Inc.
Condensed Consolidated Statements of Changes in Stockholders' Equity
(Unaudited)
Permanent EquityTemporary Equity
 Common StockAdditional
Paid-in
Capital
Retained Earnings (Accumulated
Deficit)
Accumulated
Other
Comprehensive
Income (Loss)
Treasury StockTotal
Attributed To
Virtus Investment Partners, Inc.
Non-
controlling
Interests
Total
Equity
Redeemable
Non-
controlling
Interests
(in thousands, except per share data)SharesPar ValueSharesAmount
Balances at December 31, 20227,181,554 $120 $1,286,244 $130,261 $(358)4,851,693 $(599,248)$817,019 $5,917 $822,936 $113,718 
Net income (loss)— — — 38,624 — — — 38,624 765 39,389 (4,746)
Foreign currency translation adjustments— — — — 99 — — 99 — 99 — 
Net subscriptions (redemptions) and other— —  — — — —  (300)(300)(2,342)
Cash dividends declared ($1.65 per common share)
— — — (13,093)— — — (13,093)— (13,093)— 
Issuance of common shares related to employee stock transactions106,840 1 (1)— — — —  —  — 
Taxes paid on stock-based compensation— — (12,209)— — — — (12,209)— (12,209)— 
Stock-based compensation— — 7,475 — — — — 7,475 — 7,475 — 
Balances at March 31, 20237,288,394 $121 $1,281,509 $155,792 $(259)4,851,693 $(599,248)$837,915 $6,382 $844,297 $106,630 
Balances at December 31, 20237,087,728 $122 $1,300,999 $207,356 $(87)5,075,500 $(644,464)$863,926 $4,363 $868,289 $104,869 
Net income (loss)— — — 29,858 — — — 29,858 391 30,249 7,618 
Foreign currency translation adjustments— — — — (100)— — (100)— (100)— 
Net subscriptions (redemptions) and other— —  — — — —  (403)(403)2,698 
Cash dividends declared ($1.90 per common share)
— — — (14,191)— — — (14,191)— (14,191)— 
Repurchases of common shares(21,108)— — — — 21,108 (4,999)(4,999)— (4,999)— 
Issuance of common shares related to employee stock transactions61,261 — — — — — —  —  — 
Taxes paid on stock-based compensation— — (9,852)— — — — (9,852)— (9,852)— 
Stock-based compensation— — 7,010 — — — — 7,010 — 7,010 — 
Balances at March 31, 20247,127,881 $122 $1,298,157 $223,023 $(187)5,096,608 $(649,463)$871,652 $4,351 $876,003 $115,185 










The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Virtus Investment Partners, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Organization and Business
Virtus Investment Partners, Inc. (the "Company," "we," "us," "our" or "Virtus"), a Delaware corporation, operates in the investment management industry through its subsidiaries.

The Company provides investment management and related services to institutions and individuals. The Company's investment strategies are offered to institutional clients through institutional separate and commingled accounts, including structured products. The Company’s retail investment management services are provided to individuals through products consisting of: mutual funds registered pursuant to the Investment Company Act of 1940, as amended ("U.S. retail funds"); Undertaking for Collective Investment in Transferable Securities and Qualifying Investor Funds (collectively, "global funds") and collectively with U.S. retail funds, variable insurance funds, and exchange-traded funds ("ETFs"), (the "open-end funds"); closed-end funds (collectively, with open-end funds, the "funds"); and retail separate accounts that include intermediary-sold and private client accounts. The Company also provides subadvisory services to other investment advisers.


2. Basis of Presentation and Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company’s financial condition and results of operations. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC"). The Company’s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.

New Accounting Standards Not Yet Implemented
In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280). This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards. This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.



6

3. Revenues
The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers. Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed. The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance. Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.

Investment Management Fees by Source    
The following table summarizes investment management fees by source:
 Three Months Ended
March 31,
(in thousands)20242023
Investment management fees
Open-end funds$78,680 $71,266 
Closed-end funds14,394 14,678 
Retail separate accounts48,981 40,079 
Institutional accounts46,305 38,455 
Total investment management fees$188,360 $164,478 
    

4. Acquisitions
AlphaSimplex Group, LLC
On April 1, 2023, the Company completed the acquisition of AlphaSimplex Group, LLC ("AlphaSimplex"), which was accounted for in accordance with Accounting Standards Codification ("ASC") 805, Business Combinations ("ASC 805"). The total purchase price paid of $113.4 million was allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the date of the acquisition. Goodwill of $48.3 million and intangible assets of $55.4 million were recorded for the acquisition.


5. Intangible Assets, Net
Below is a summary of intangible assets, net:
Definite-LivedIndefinite-LivedTotal
(in thousands)Gross Book ValueAccumulated AmortizationNet Book ValueNet Book ValueNet Book Value
Balances at December 31, 2023$806,655 $(416,834)$389,821 $42,298 $432,119 
Intangible amortization— (15,335)(15,335)— (15,335)
Balances at March 31, 2024$806,655 $(432,169)$374,486 $42,298 $416,784 
Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows:
Fiscal Year
Amount
(in thousands)
Remainder of 2024$40,964 
202551,532 
202650,552 
202747,450 
202841,787 
2029 and thereafter142,201 
Total$374,486 

7


6. Investments
Investments consist primarily of investments in the Company's sponsored products. The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March 31, 2024 and December 31, 2023 were as follows:
(in thousands)March 31,
2024
December 31, 2023
Investment securities - fair value$90,497 $97,304 
Equity method investments (1)23,208 22,710 
Nonqualified retirement plan assets13,743 12,682 
Total investments$127,448 $132,696 
(1)    The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.

Investment Securities - fair value
Investment securities - fair value consist of investments in the Company's sponsored funds and separately managed accounts. The composition of the Company’s investment securities - fair value was as follows:
March 31, 2024December 31, 2023
(in thousands)CostFair ValueCostFair Value
Investment Securities - fair value
Sponsored funds$69,067 $69,514 $80,794 $77,433 
Equity securities16,875 20,983 16,353 19,871 
Total investment securities - fair value$85,942 $90,497 $97,147 $97,304 
For the three months ended March 31, 2024 and 2023, the Company recognized net realized losses of $0.4 million and net realized gains $1.3 million, respectively, related to its investment securities - fair value.


7. Fair Value Measurements
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
March 31, 2024  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$92,458 $ $ $92,458 
Investment securities - fair value
Sponsored funds69,514   69,514 
Equity securities20,983   20,983 
Nonqualified retirement plan assets13,743   13,743 
Total assets measured at fair value$196,698 $ $ $196,698 
Liabilities
Contingent consideration$ $ $41,708 $41,708 
Total liabilities measured at fair value$ $ $41,708 $41,708 

8

December 31, 2023  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$197,240 $ $ $197,240 
Investment securities - fair value
Sponsored funds77,433   77,433 
Equity securities19,871   19,871 
Nonqualified retirement plan assets12,682   12,682 
Total assets measured at fair value$307,226 $ $ $307,226 
Liabilities
Contingent consideration$ $ $56,200 $56,200 
Total liabilities measured at fair value$ $ $56,200 $56,200 
The following is a discussion of the valuation methodologies used for the Company’s assets measured at fair value:

Cash equivalents represent investments in money market funds. Cash investments in money market funds are valued using published net asset values and are classified as Level 1.

Sponsored funds represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager. The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1. The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.

Equity securities represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.

Nonqualified retirement plan assets represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.

Contingent consideration represents liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ") transactions . The continent consideration related to the WCM transaction as of March 31, 2024 was $11.1 million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates. The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%). The NFJ contingent consideration liability as of March 31, 2024 was $30.6 million and represents the fair value of the projected future revenue participation payments. The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets. The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%). These liabilities are categorized as Level 3.

9

The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:
Three Months Ended
March 31,
(in thousands)20242023
Contingent consideration, beginning of period$56,200 $78,100 
Reduction for payments made(14,492)(16,390)
Contingent consideration, end of period$41,708 $61,710 

Cash, accounts receivable, accounts payable and accrued liabilities equal or approximate fair value based on the short-term nature of these instruments.


8. Equity Transactions
Dividends Declared
On February 21, 2024, the Company declared a quarterly cash dividend of $1.90 per common share to be paid on May 15, 2024 to shareholders of record at the close of business on April 30, 2024.

Common Stock Repurchases
During the three months ended March 31, 2024, the Company repurchased 21,108 common shares at a weighted average price of $236.84 per share for a total cost, including fees and expenses, of $5.0 million under its share repurchase program. As of March 31, 2024, 583,437 shares remained available for repurchase. Under the terms of the program, the Company may repurchase shares of its common stock from time to time at its discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price and prevailing market and business conditions. The program, which has no specified term, may be suspended or terminated at any time.


9. Accumulated Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive income (loss) were as follows:
Three Months Ended
March 31,
(in thousands)20242023
Balance at beginning of period$(87)$(358)
Net current-period other comprehensive income (loss) (1)(100)99 
Balance at end of period$(187)$(259)
(1)     Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively.


10. Stock-Based Compensation
Equity-based awards, including restricted stock units ("RSUs"), performance stock units ("PSUs"), stock options and unrestricted shares of common stock, may be granted to officers, employees and directors of the Company pursuant to the Company's Omnibus Incentive and Equity Plan (the "Omnibus Plan"). At March 31, 2024, 375,169 shares of common stock remained available for issuance of the 3,370,000 shares that are authorized for issuance under the Omnibus Plan.     
Stock-based compensation expense is summarized as follows:
Three Months Ended March 31,
(in thousands)20242023
Stock-based compensation expense$6,831 $5,749 


10

Restricted Stock Units
Each RSU entitles the holder to one share of common stock when the restriction expires. RSUs may be time-vested or performance-contingent PSUs that convert into RSUs after performance measurement is complete and generally vest in one to three years. Shares that are issued upon vesting are newly issued shares from the Omnibus Plan and are not issued from treasury stock.

RSU activity, inclusive of PSUs, for the three months ended March 31, 2024 is summarized as follows: 
Number
of Shares
Weighted Average
Grant Date
Fair Value
Outstanding at December 31, 2023344,717 $204.48 
Granted108,658 $235.14 
Forfeited(8,333)$261.65 
Settled(103,849)$229.92 
Outstanding at March 31, 2024341,193 $205.10 

For the three months ended March 31, 2024 and 2023, a total of 42,588 and 70,716 RSUs, respectively, were withheld by the Company as a result of net share settlements to settle minimum employee tax withholding obligations and for which the Company paid $9.9 million and $12.2 million respectively, in minimum employee tax withholding obligations. These net share settlements had the effect of share repurchases by the Company as they reduced the number of shares that would have otherwise been issued as a result of the vesting.

During the three months ended March 31, 2024 and 2023, the Company granted 26,733 and 44,291 PSUs, respectively, that contain performance-based metrics in addition to a service condition. Compensation expense for PSUs is generally recognized over a three-year service period based upon the value determined using a combination of (i) the intrinsic value method for awards that contain a performance metric that represents a "performance condition" in accordance with ASC 718, Stock Compensation ("ASC 718") and (ii) the Monte Carlo simulation valuation model for awards that contain a "market condition" performance metric under ASC 718. Compensation expense for PSU awards that contain a market condition is fixed at the date of grant and will not be adjusted in future periods based upon the achievement of the market condition. Compensation expense for PSU awards with a performance condition is recorded each period based upon a probability assessment of the expected outcome of the performance metric with a final adjustment upon measurement at the end of the performance period.

As of March 31, 2024, unamortized stock-based compensation expense for unvested RSUs and PSUs was $45.5 million with a weighted-average remaining contractual life of 1.6 years.


11. Earnings (Loss) Per Share
Earnings (loss) per share ("EPS") is calculated in accordance with ASC 260, Earnings per Share. Basic EPS is computed by dividing net income (loss) attributable to Virtus Investment Partners, Inc. by the weighted-average number of common shares outstanding for the period, excluding dilution for potential common stock issuances. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, including shares issuable upon the vesting of RSUs and stock option exercises using the treasury stock method, as determined under the if-converted method.
11

The computation of basic and diluted EPS is as follows: 
 Three Months Ended March 31,
(in thousands, except per share amounts)20242023
Net Income (Loss)$37,867 $34,643 
Noncontrolling interests(8,009)3,981 
Net Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,858 $38,624 
Shares:
Basic: Weighted-average number of shares outstanding7,119 7,245 
Plus: Incremental shares from assumed conversion of dilutive instruments168 165 
Diluted: Weighted-average number of shares outstanding7,287 7,410 
Earnings (Loss) per Share—Basic$4.19 $5.33 
Earnings (Loss) per Share—Diluted$4.10 $5.21 

The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.
 Three Months Ended March 31,
(in thousands)20242023
Restricted stock units1 40 
Total anti-dilutive securities1 40 


12. Income Taxes
In calculating the provision for income taxes, the Company uses an estimate of the annual effective tax rate based upon the facts and circumstances at each interim period. On a quarterly basis, the estimated annual effective tax rate is adjusted, as appropriate, based upon changes in facts and circumstances, if any, compared to those forecasted at the beginning of the fiscal year and at each interim period thereafter.

The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March 31, 2024 and 2023, respectively. The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain Company investments.


13. Debt
Credit Agreement
The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026. The Company repaid $0.7 million outstanding under the Term Loan during the three months ended March 31, 2024 and had $258.1 million outstanding under the Term Loan at March 31, 2024. In accordance with ASC 835, Interest, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March 31, 2024.


14. Commitments and Contingencies
Legal Matters
The Company is involved from time to time in litigation and arbitration, as well as examinations, inquiries and investigations by various regulatory bodies, involving its compliance with, among other things, securities laws, client investment guidelines, laws governing the activities of broker-dealers and other laws and regulations affecting its products and other activities.

12

The Company records a liability when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on information currently available, available insurance coverage, indemnities and established reserves, the Company believes that the outcomes of its legal and regulatory proceedings are not likely, either individually or in the aggregate, to have a material adverse effect on the Company's results of operations, cash flows or its consolidated financial condition. However, in the event of unexpected subsequent developments, and given the inherent unpredictability of these legal and regulatory matters, the Company can provide no assurance that its assessment of any legal matter will reflect the ultimate outcome, and an adverse outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.


15. Redeemable Noncontrolling Interests
Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate. Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value. The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement. The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests. The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity. These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.

Redeemable noncontrolling interests for the three months ended March 31, 2024 included the following amounts:
(in thousands)CIPAffiliate Noncontrolling InterestsTotal
Balances at December 31, 2023$30,643 $74,226 $104,869 
Net income (loss) attributable to noncontrolling interests1,429 1,829 3,258 
Changes in redemption value (1) 4,360 4,360 
Total net income (loss) attributable to noncontrolling interests1,429 6,189 7,618 
Affiliate equity sales (purchases) (419)(419)
Net subscriptions (redemptions) and other3,117  3,117 
Balances at March 31, 2024$35,189 $79,996 $115,185 
(1)     Relates to noncontrolling interests redeemable at other than fair value.

16. Consolidation
The condensed consolidated financial statements include the accounts of the Company, its subsidiaries and investment products that are consolidated. A voting interest entity ("VOE") is consolidated when the Company is considered to have a controlling financial interest, which is typically present when the Company owns a majority of the voting interest in an entity or otherwise has the power to govern the financial and operating policies of the entity.

The Company evaluates any variable interest entity ("VIE") in which the Company has a variable interest for consolidation. A VIE is an entity in which either (i) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support, or (ii) where as a group, the holders of the equity investment at risk do not possess any one of the following: (a) the power through voting or similar rights to direct the activities that most significantly impact the entity's economic performance, (b) the obligation to absorb expected losses or the right to receive expected residual returns of the entity, or (c) proportionate voting and economic interests and where substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately fewer voting rights. If an entity has any of these characteristics, it is considered a VIE and is required to be consolidated by its primary beneficiary. The primary beneficiary is the entity that has both the power to direct the activities that most significantly impact the VIE's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.
13


In the normal course of its business, the Company sponsors various investment products, some of which are consolidated by the Company. CIP includes both VOEs, made up primarily of U.S. retail funds and ETFs in which the Company holds a controlling financial interest, and VIEs, which consist of collateralized loan obligations ("CLO") and certain global and private funds ("GF") of which the Company is considered the primary beneficiary. The consolidation and deconsolidation of these investment products have no impact on the Company's net income (loss). The Company's risk with respect to these investment products is limited to its beneficial interests in these products. The Company has no right to the benefits from, and does not bear the risks associated with, these investment products beyond the Company's investments in, and fees generated from, these products.

The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023:
As of
 March 31, 2024December 31, 2023
VOEsVIEsVOEsVIEs
(in thousands)CLOs GFsCLOsGFs
Cash and cash equivalents$1,271 $119,914 $2,612 $1,223 $98,101 $2,088 
Investments40,591 1,962,697 77,937 30,985 1,972,342 79,386 
Other assets616 30,064 1,168 174 41,985 1,076 
Notes payable (1,922,051)  (1,922,243) 
Securities purchased payable and other liabilities(1,019)(88,270)(1,999)(740)(89,167)(616)
Noncontrolling interests(12,311)(4,351)(22,878)(7,316)(4,363)(23,327)
Net interests in CIP$29,148 $98,003 $56,840 $24,326 $96,655 $58,607 

Consolidated CLOs
The majority of the Company's CIP that are VIEs are CLOs. The financial information of certain CLOs is included on the Company's condensed consolidated financial statements on a one-month lag based upon the availability of their financial information. A majority-owned consolidated private fund, whose primary purpose is to invest in CLOs for which the Company serves as the collateral manager, is also included. At March 31, 2024, the Company consolidated seven CLOs.

Investments of CLOs
The CLOs held investments of $2.0 billion at March 31, 2024, consisting of bank loan investments that comprise the majority of the CLOs' portfolio asset collateral and are senior secured corporate loans across a variety of industries. These bank loan investments mature at various dates between 2024 and 2032 and generally pay interest at SOFR plus a spread.

Notes Payable of CLOs
The CLOs held notes payable with a total value, at par, of $2.1 billion at March 31, 2024, consisting of senior secured floating rate notes payable with a par value of $1.9 billion and subordinated notes with a par value of $215.1 million. These note obligations bear interest at variable rates based on SOFR plus a pre-defined spread.

The Company's beneficial interests and maximum exposure to loss related to these consolidated CLOs is limited to (i) ownership in the subordinated notes and (ii) accrued management fees. The secured notes of the consolidated CLOs have contractual recourse only to the related assets of the CLO and are classified as financial liabilities. Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, Consolidation (Topic 810) ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March 31, 2024, as shown in the table below:
(in thousands)
Subordinated notes$96,416 
Accrued investment management fees1,587 
Total Beneficial Interests$98,003 

14

The following table represents income and expenses of the consolidated CLOs included on the Company’s Condensed Consolidated Statements of Operations for the period indicated:
Three Months Ended March 31, 2024
(in thousands)
Income:
Realized and unrealized gain (loss), net$1 
Interest income49,280 
Total Income49,281 
Expenses:
Other operating expenses499 
Interest expense40,011 
Total Expense40,510 
Noncontrolling interests(391)
Net Income (Loss) Attributable to CLOs$8,380 

The following table represents the Company’s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:
Three Months Ended March 31, 2024
(in thousands)
Distributions received and unrealized gains (losses) on the subordinated notes held by the Company$6,083 
Investment management fees2,297 
Total Economic Interests$8,380 

Fair Value Measurements of CIP
The assets and liabilities of CIP measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
As of March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$119,914 $ $ $119,914 
Debt investments 2,003,579 47,551 2,051,130 
Equity investments 29,469 384 242 30,095 
Total assets measured at fair value$149,383 $2,003,963 $47,793 $2,201,139 
Liabilities
Notes payable$ $1,922,051 $ $1,922,051 
Short sales485   485 
Total liabilities measured at fair value$485 $1,922,051 $ $1,922,536 

15

As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$98,101 $ $ $98,101 
Debt investments241 2,012,760 36,616 2,049,617 
Equity investments32,642 8 446 33,096 
Total assets measured at fair value$130,984 $2,012,768 $37,062 $2,180,814 
Liabilities
Notes payable$ $1,922,243 $ $1,922,243 
Short sales518   518 
Total liabilities measured at fair value$518 $1,922,243 $ $1,922,761 

The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company’s CIP measured at fair value:

Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.

Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service. Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities. Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service. Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.

Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security. These securities are valued using unadjusted prices from an independent pricing service.

Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline. Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.

Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13. Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services. The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.

The securities purchased payable at March 31, 2024 and December 31, 2023 approximated fair value due to the short-term nature of the instruments.

16

The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:
 Three Months Ended March 31,
 (in thousands)
20242023
Balance at beginning of period$37,062 $43,581 
Realized and unrealized gains (losses), net(324)111 
Purchases 4 
Sales(14,625)(7,195)
Transfers to Level 2(13,468)(35,747)
Transfers from Level 239,148 9,904 
Balance at end of period (1)$47,793 $10,658 
(1)The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment. Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.

Nonconsolidated VIEs
The Company serves as the collateral manager for other CLOs that are not consolidated. The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees. The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length.
    
The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance. At March 31, 2024, the carrying value and maximum risk of loss related to the Company's interest in these VIEs was $29.1 million.


17

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward Looking Statements
This Quarterly Report on Form 10-Q contains statements that are, or may be considered to be, forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements that are not historical facts, including statements about our beliefs or expectations, are "forward-looking statements." These statements may be identified by such forward-looking terminology as "expect," "estimate," "intent," "plan," "intend," "believe," "anticipate," "may," "will," "should," "could," "continue," "project," "opportunity," "predict," "would," "potential," "future," "forecast," "guarantee," "assume," "likely," "target" or similar statements or variations of such terms.

Our forward-looking statements are based on a series of expectations, assumptions and projections about the Company and the markets in which we operate, are not guarantees of future results or performance, and involve substantial risks and uncertainty, including assumptions and projections concerning our assets under management, net asset inflows and outflows, operating cash flows, business plans and ability to borrow, for all future periods. All forward-looking statements contained in this Quarterly Report on Form 10-Q are as of the date of this Quarterly Report on Form 10-Q only.

We can give no assurance that such expectations or forward-looking statements will prove to be correct. Actual results may differ materially. We do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections, or other circumstances occurring after the date of this Quarterly Report on Form 10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. If there are any future public statements or disclosures by us that modify or impact any of the forward-looking statements contained in or accompanying this Quarterly Report on Form 10-Q, such statements or disclosures will be deemed to modify or supersede such statements in this Quarterly Report on Form 10-Q.

Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including those discussed under "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in our 2023 Annual Report on Form 10-K and this Quarterly Report on Form 10-Q, resulting from: (i) any reduction in our assets under management; (ii) inability to achieve the expected benefits of strategic transactions; (iii) withdrawal, renegotiation or termination of investment advisory agreements; (iv) damage to our reputation; (v) inability to satisfy financial debt covenants and required payments; (vi) inability to attract and retain key personnel; (vii) challenges from competition; (viii) adverse developments related to unaffiliated subadvisers; (ix) negative changes in key distribution relationships; (x) interruptions, breaches, or failures of technology systems; (xi) loss on our investments; (xii) lack of sufficient capital on satisfactory terms; (xiii) adverse regulatory and legal developments; (xiv) failure to comply with investment guidelines or other contractual requirements; (xv) adverse civil litigation, government investigations, or proceedings; (xvi) unfavorable changes in tax laws or limitations; (xvii) inability to make common stock dividend payments; (xviii) impediments from certain corporate governance provisions; (xix) losses or costs not covered by insurance; (xx) impairment of goodwill or other intangible assets; and other risks and uncertainties. Any occurrence of, or any material adverse change in, one or more risk factors or risks and uncertainties referred to above, in our 2023 Annual Report on Form 10-K, this Quarterly Report on Form 10-Q and our other periodic reports filed with the Securities and Exchange Commission (the "SEC") could materially and adversely affect our operations, financial results, cash flows, prospects and liquidity.

Certain other factors that may impact our continuing operations, prospects, financial results and liquidity, or that may cause actual results to differ from such forward-looking statements, are discussed or included in the Company’s periodic reports filed with the SEC and are available on our website at www.virtus.com under "Investor Relations." You are urged to carefully consider all such factors.

Overview
    Our Business
We provide investment management and related services to institutions and individuals. We use a multi-manager, multi-style approach, offering investment strategies from affiliated managers, each having its own distinct investment style, autonomous investment process and individual brand, as well as from select unaffiliated managers for certain of our retail funds. By offering a broad array of products, we believe we can appeal to a greater number of investors and have offerings across market cycles and through changes in investor preferences. Our earnings are primarily from asset-based fees charged for services relating to these various products, including investment management, fund administration, distribution, and shareholder services.

18

We offer investment strategies for institutional and individual investors in different investment products and through multiple distribution channels. Our investment strategies are available in a diverse range of styles and disciplines, managed by differentiated investment managers. We have offerings in various asset classes (equity, fixed income, multi-asset and alternatives), geographies (domestic, global, international and emerging), market capitalizations (large, mid and small), styles (growth, core and value) and investment approaches (fundamental and quantitative). Our institutional products are offered through institutional separate accounts and commingled accounts, including structured products to a variety of institutional clients. Our products include open-end funds, closed-end funds and retail separate accounts. We also provide subadvisory services to other investment advisers.

Our institutional distribution resources include affiliate-specific sales teams primarily focused on the U.S. market, supported by shared consultant relations and U.S. and non-U.S. institutional sales distribution. Our institutional products are marketed through relationships with consultants as well as directly to clients. We target key market segments, including foundations and endowments, corporations, public and private pension plans, sovereign wealth funds and subadvisory relationships.

Our retail distribution resources in the U.S. consist of regional sales professionals, a national account relationship group and specialized teams for retirement and ETFs. Our U.S. retail funds and retail separate accounts are distributed through financial intermediaries. We have broad distribution access in the U.S. retail market, with distribution partners that include national and regional broker-dealers, independent broker-dealers and registered investment advisers, banks and insurance companies. In many of these firms, we have a number of products that are on preferred "recommended" lists and on fee-based advisory programs. Our private client business is marketed directly to individual clients by financial advisory teams at our affiliated investment managers.

Financial Highlights 
Net income per diluted share was $4.10 in the first quarter of 2024, a decrease of $1.11, or 21.3%, compared to net income per diluted share of $5.21 in the first quarter of 2023.
Total sales were $7.6 billion in the first quarter of 2024, an increase of $1.3 billion, or 21.6%, from $6.2 billion in the first quarter of 2023. Net flows were $(1.2) billion in the first quarter of 2024 compared to net flows of $(1.9) billion in the first quarter of 2023.
Assets under management were $179.3 billion at March 31, 2024, an increase of $24.5 billion, or 15.8%, from March 31, 2023.

Assets Under Management
At March 31, 2024, total assets under management were $179.3 billion, representing an increase of $24.5 billion, or 15.8%, from March 31, 2023, and an increase of $7.1 billion, or 4.1%, from December 31, 2023. The increase in total assets under management from March 31, 2023 included $25.7 billion from positive market performance and $7.8 billion from the acquisition of AlphaSimplex Group LLC on April 1, 2023 ("AlphaSimplex"), partially offset by $6.6 billion of net outflows. The increase in total assets under management from December 31, 2023 included $8.7 billion from positive market performance partially offset by $1.2 billion of net outflows.


19

Assets Under Management by Product
The following table summarizes our assets under management by product:
As of March 31,Change
(in millions)20242023$%
Open-End Funds (1)$57,818 $53,865 $3,953 7.3 %
Closed-End Funds10,064 10,358 (294)(2.8)%
Retail Separate Accounts46,816 37,397 9,419 25.2 %
Institutional Accounts (2)64,613 53,229 11,384 21.4 %
Total$179,311 $154,849 $24,462 15.8 %
Average Assets Under Management (3)$173,358 $152,361 $20,997 13.8 %
(1)Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds.
(2)Represents assets under management of institutional separate and commingled accounts including structured products.
(3)Averages are calculated as follows:
Funds - average daily or weekly balances
Retail Separate Accounts - prior-quarter ending balances
Institutional Accounts - average of month-end balances

Asset Flows by Product    
The following table summarizes asset flows by product:
Three Months Ended
March 31,
(in millions)20242023
Open-End Funds (1)
Beginning balance$56,062 $53,000 
Inflows3,476 3,011 
Outflows(4,104)(4,792)
Net flows(628)(1,781)
Market performance2,560 2,771 
Other (2)(176)(125)
Ending balance$57,818 $53,865 
Closed-End Funds
Beginning balance$10,026 $10,361 
Inflows— 
Outflows— — 
Net flows— 
Market performance239 205 
Other (2)(201)(212)
Ending balance$10,064 $10,358 
Retail Separate Accounts
Beginning balance$43,202 $35,352 
Inflows2,373 1,367 
Outflows(1,695)(1,288)
Net flows678 79 
Market performance2,936 1,966 
Other (2)— — 
Ending balance$46,816 $37,397 
20

Three Months Ended
March 31,
(in millions)20242023
Institutional Accounts (3)
Beginning balance$62,969 $50,663 
Inflows1,734 1,852 
Outflows(3,022)(2,047)
Net flows(1,288)(195)
Market performance3,001 2,906 
Other (2)(69)(145)
Ending balance$64,613 $53,229 
Total
Beginning balance$172,259 $149,376 
Inflows7,583 6,234 
Outflows(8,821)(8,127)
Net flows(1,238)(1,893)
Market performance8,736 7,848 
Other (2)(446)(482)
Ending balance$179,311 $154,849 
(1)Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds.
(2)Represents open-end and closed-end fund distributions net of reinvestments, the net change in assets from cash management strategies, and the impact of non-sales related activities such as asset acquisitions/(dispositions), seed capital investments/(withdrawals), current income or capital returned by structured products and the use of leverage.
(3)Represents assets under management of institutional separate and commingled accounts including structured products.


Assets Under Management by Asset Class
The following table summarizes assets under management by asset class:
 As of March 31,Change% of Total
(in millions)20242023$%20242023
Asset Class
Equity$103,501 $87,511 $15,990 18.3 %57.7 %56.5 %
Fixed income37,037 36,596 441 1.2 %20.6 %23.6 %
Multi-asset (1)21,975 20,597 1,378 6.7 %12.3 %13.3 %
Alternatives (2)16,798 10,145 6,653 65.6 %9.4 %6.6 %
Total$179,311 $154,849 $24,462 15.8 %100.0 %100.0 %
 
(1)    Consists of strategies and client accounts with substantial holdings in at least two of the following asset classes: equity, fixed income and alternatives.
(2)    Consists of managed futures, event-driven, real estate securities, infrastructure, long/short and other strategies.


21

Average Assets Under Management and Average Fees Earned
The following tables summarize the average management fees earned in basis points and average assets under management:
 Three Months Ended March 31,
Average Fee Earned
(expressed in basis points)
Average Assets Under
 Management
 (in millions) (3)
 2024202320242023
Products
Open-End Funds (1)49.9 47.6 $56,828 $54,141 
Closed-End Funds58.7 57.1 9,862 10,424 
Retail Separate Accounts43.9 44.2 43,202 35,352 
Institutional Accounts (2)30.8 31.8 63,466 52,444 
All Products41.9 42.0 $173,358 $152,361 
(1)Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds.
(2)Represents assets under management of institutional separate and commingled accounts including structured products.
(3)Averages are calculated as follows:
Funds - average daily or weekly balances
Retail Separate Accounts - prior-quarter ending balances
Institutional Accounts - average of month-end balances

Average fees earned represent investment management fees, net of revenue-related adjustments, divided by average net assets, excluding the impact of consolidated investment products ("CIP"). Revenue-related adjustments are based on specific agreements and reflect the portion of investment management fees passed-through to third-party client intermediaries for services to investors in sponsored investment products. Fund fees are calculated based on average daily or weekly net assets. Retail separate account fees are calculated based on the end of the preceding or current quarter’s asset values or on an average of month-end balances. Institutional account fees are calculated based on an average of month-end balances, an average of current quarter’s asset values or on a combination of the underlying cash flows and the principal value of the product. Average fees earned will vary based on several factors, including the asset mix and expense reimbursements to the funds.

The average fee rate earned on all products for the three months ended March 31, 2024 decreased by 0.1 basis points compared to the same period in the prior year primarily due to a shift in asset mix to lower fee assets partially offset by the addition of alternative strategies with higher fee rates from the AlphaSimplex acquisition.

22

Results of Operations
Summary Financial Data
Three Months Ended
March 31,
Change
(in thousands)20242023$%
Investment management fees$188,360 $164,478 $23,882 14.5 %
Other revenue33,682 33,396 286 0.9 %
Total revenues222,042 197,874 24,168 12.2 %
Total operating expenses189,736 169,295 20,441 12.1 %
Operating income (loss)32,306 28,579 3,727 13.0 %
Other income (expense), net5,501 4,923 578 11.7 %
Interest income (expense), net8,891 9,844 (953)(9.7)%
Income (loss) before income taxes46,698 43,346 3,352 7.7 %
Income tax expense (benefit)8,831 8,703 128 1.5 %
Net income (loss)37,867 34,643 3,224 9.3 %
Noncontrolling interests(8,009)3,981 (11,990)(301.2)%
Net Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,858 $38,624 $(8,766)(22.7)%
Earnings (loss) per share-diluted$4.10 $5.21 $(1.11)(21.3)%

In the first quarter of 2024, total revenues increased 12.2% to $222.0 million from $197.9 million in the first quarter of 2023, primarily as a result of increased average assets under management during the current year period compared to the prior year period. Operating income increased $3.7 million to $32.3 million in the first quarter of 2024 compared to $28.6 million in the first quarter of 2023, due primarily to the aforementioned increased revenue, partially offset by increased operating expenses due to the addition of AlphaSimplex.

Revenues
Revenues by source were as follows:
Three Months Ended
March 31,
Change
(in thousands)20242023$%
Investment management fees
Open-end funds$78,680 $71,266 $7,414 10.4 %
Closed-end funds14,394 14,678 (284)(1.9)%
Retail separate accounts48,981 40,079 8,902 22.2 %
Institutional accounts46,305 38,455 7,850 20.4 %
Total investment management fees188,360 164,478 23,882 14.5 %
Distribution and service fees14,030 14,153 (123)(0.9)%
Administration and shareholder service fees18,678 18,359 319 1.7 %
Other income and fees974 884 90 10.2 %
Total Revenues$222,042 $197,874 $24,168 12.2 %

Investment Management Fees
Investment management fees are earned based on a percentage of assets under management and are paid pursuant to the terms of the respective investment management agreements, which generally require monthly or quarterly payments. Investment management fees increased by $23.9 million, or 14.5%, for the three months ended March 31, 2024, compared to the same period in the prior year primarily due to the increase in average assets under management.

Distribution and Service Fees
Distribution and service fees are sales- and asset-based fees earned from open-end funds for marketing and
23

distribution services. Distribution and service fees remained consistent during the three months ended March 31, 2024, compared to the same period in the prior year.

Administration and Shareholder Service Fees
Administration and shareholder service fees represent fees earned for fund administration and shareholder services from our U.S. retail funds, ETFs and certain closed-end funds. Fund administration and shareholder service fees increased by $0.3 million, or 1.7%, for the three months ended March 31, 2024, compared to the same period in the prior year primarily due to the addition of AlphaSimplex.

Other Income and Fees
Other income and fees primarily represent fees related to other fee-earning assets and contingent sales charges earned from investor redemptions of certain shares sold without a front-end sales charge. Other income and fees remained consistent during the three months ended March 31, 2024, compared to the same period in the prior year.

Operating Expenses
Operating expenses by category were as follows:
Three Months Ended
March 31,
Change
(in thousands)20242023$%
Operating expenses
Employment expenses$115,163 $98,614 $16,549 16.8 %
Distribution and other asset-based expenses24,348 23,715 633 2.7 %
Other operating expenses31,375 30,730 645 2.1 %
Other operating expenses of CIP690 700 (10)(1.4)%
Restructuring expense797 — 797 N/M
Depreciation expense2,028 1,145 883 77.1 %
Amortization expense15,335 14,391 944 6.6 %
Total operating expenses$189,736 $169,295 $20,441 12.1 %
N/M - Not meaningful

Employment Expenses
Employment expenses consist of fixed and variable compensation and related employee benefit costs. Employment expenses of $115.2 million increased by $16.5 million, or 16.8%, compared to the same period in the prior year primarily due to the addition of AlphaSimplex and an increase in profit- and sales-based compensation in the current year.

Distribution and Other Asset-Based Expenses
Distribution and other asset-based expenses consist primarily of payments to third-party client intermediaries for providing services to investors in sponsored investment products. These payments are primarily based on assets under management. Distribution and other asset-based expenses also include the amortization of deferred sales commissions related to up-front commissions on shares sold without a front-end sales charge to shareholders. The deferred sales commissions are amortized on a straight-line basis over the period commissions are recovered from distribution fee revenues and contingent sales charges received upon redemption of shares. During the three months ended March 31, 2024, distribution and other asset-based expenses increased $0.6 million, or 2.7%, compared to the same period in the prior year primarily due to an increase in assets under management in share classes that have asset-based distribution and other asset-based expenses.

Other Operating Expenses
Other operating expenses primarily consist of investment research and technology costs, professional fees, travel and distribution-related costs, rent and occupancy expenses, and other business costs. Other operating expenses increased $0.6 million, or 2.1%, for the three months ended March 31, 2024, compared to the same period in the prior year. The increase was primarily attributable to the addition of AlphaSimplex partially offset by lower professional fees in the current year period.

24

Other Operating Expenses of CIP
Other operating expenses of CIP remained consistent during the three months ended March 31, 2024 compared to the same period in the prior year.

Depreciation Expense
Depreciation expense consists primarily of the straight-line depreciation of furniture, equipment and leasehold improvements. Depreciation expense increased $0.9 million, or 77.1%, for the three months ended March 31, 2024, compared to the respective period in the prior year. The increase was primarily due to the addition of AlphaSimplex and software and equipment purchases in the prior year and depreciation expense for new office space.

Amortization Expense
Amortization expense consists of the amortization of definite-lived intangible assets over their estimated useful lives. Amortization expense increased $0.9 million, or 6.6%, for the three months ended March 31, 2024, compared to the same period in the prior year, primarily due to the addition of AlphaSimplex.

Other Income (Expense)
Other Income (Expense), net by category were as follows:
Three Months Ended
March 31,
Change
(in thousands)20242023$%
Other Income (Expense)
Realized and unrealized gain (loss) on investments, net$3,416 $2,670 $746 27.9 %
Realized and unrealized gain (loss) of CIP, net1,535 2,596 (1,061)(40.9)%
Other income (expense), net550 (343)893 (260.3)%
Total Other Income (Expense), net$5,501 $4,923 $578 11.7 %

Realized and unrealized gain (loss) on investments, net
Realized and unrealized gain (loss) on investments, net changed during the three months ended March 31, 2024 by $0.7 million, compared to the same period in the prior year. The realized and unrealized gains and losses reflect changes in overall market conditions for the respective periods.

Realized and unrealized gain (loss) of CIP, net
Realized and unrealized gain (loss) of CIP, net changed by $(1.1) million during the three months ended March 31, 2024, compared to the same period in the prior year. The change for the three months ended March 31, 2024 consisted primarily of unrealized losses of $17.9 million due to changes in market values of leveraged loans, partially offset by changes in unrealized gains of $16.8 million related to the value of the notes payable.

Other income (expense), net    
Other income (expense), net changed by $0.9 million during the three months ended March 31, 2024, compared to the same period in the prior year primarily due to changes in the gains and losses on our equity method investments.
25


Interest Income (Expense)
Interest Income (Expense), net by category were as follows:
Three Months Ended
March 31,
Change
(in thousands)20242023$%
Interest Income (Expense)
Interest expense$(5,681)$(5,005)$(676)13.5 %
Interest and dividend income3,469 3,238 231 7.1 %
Interest and dividend income of investments of CIP51,115 46,814 4,301 9.2 %
Interest expense of CIP(40,012)(35,203)(4,809)13.7 %
Total Interest Income (Expense), net$8,891 $9,844 $(953)(9.7)%

Interest Expense
Interest expense increased $0.7 million, or 13.5%, during the three months ended March 31, 2024, compared to the same period in the prior year due primarily to higher average interest rates during the current year period.

Interest and Dividend Income
Interest and dividend income increased $0.2 million, or 7.1%, during the three months ended March 31, 2024, compared to the same period in the prior year. The increase was primarily attributable to both higher interest earned on cash balances and a higher average investment balance in the current year period compared to the prior year period.

Interest and Dividend Income of Investments of CIP    
Interest and dividend income of investments of CIP increased $4.3 million, or 9.2%, for the three months ended March 31, 2024, compared to the same period in the prior year. The increase was primarily due to higher average interest rates during the current year period and the addition of a CLO in the third quarter of 2023.

Interest Expense of CIP    
Interest expense of CIP represents interest expense on the notes payable of CIP. Interest expense of CIP increased by $4.8 million, or 13.7%, for the three months ended March 31, 2024, compared to the same period in the prior year primarily due to higher average interest rates and the addition of a CLO in the third quarter of 2023.

Income Tax Expense (Benefit)
The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March 31, 2024 and 2023, respectively. The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain of our investments.


26

Liquidity and Capital Resources
Certain Financial Data
The following table summarizes certain financial data relating to our liquidity and capital resources:
 March 31,
2024
December 31, 2023Change
(in thousands)$%
Balance Sheet Data
Cash and cash equivalents$123,880 $239,602 $(115,722)(48.3)%
Investments127,448 132,696 (5,248)(4.0)%
Contingent consideration66,704 90,938 (24,234)(26.6)%
Debt253,008 253,412 (404)(0.2)%
Redeemable noncontrolling interests115,185 104,869 10,316 9.8 %
Total equity876,003 868,289 7,714 0.9 %
 
 Three Months Ended
March 31,
Change
(in thousands)20242023$%
Cash Flow Data
Provided by (Used in):
Operating activities$(34,528)$(42,959)$8,431 (19.6)%
Investing activities(2,460)(13,145)10,685 (81.3)%
Financing activities(56,146)(115,078)58,932 (51.2)%

Overview
At March 31, 2024, we had $123.9 million of cash and cash equivalents and $127.4 million of investments, which included $90.5 million of investment securities, compared to $239.6 million of cash and cash equivalents and $132.7 million of investments, which included $97.3 million of investment securities, at December 31, 2023.

Uses of Capital
Our operating expenses consist of employee compensation and related benefit costs and other operating expenses, which primarily consist of investment research, technology costs, professional fees, distribution and occupancy costs, as well as interest on our indebtedness and income taxes. Annual incentive compensation, our largest annual operating cash expenditure, is paid in the first quarter of the year. In 2024 and 2023, we paid $146.1 million and $142.1 million, respectively, in incentive compensation earned during the years ended December 31, 2023 and 2022, respectively.

In addition to operating activities, other uses of cash could include: (i) investments in organic growth, including seeding or launching new products and expanding distribution; (ii) debt principal payments through scheduled amortization or additional paydowns; (iii) dividend payments to common stockholders; (iv) repurchases of our common stock, or withholding obligations for the net settlement of employee share transactions; (v) investments in our technology infrastructure; (vi) investments in inorganic growth opportunities that may require upfront and/or future payments; (vii) integration costs, including restructuring and severance, related to acquisitions, if any; and (viii) purchases of affiliate equity interests.
    
Capital and Reserve Requirements
Certain of our subsidiaries are registered with the SEC, Central Bank of Ireland (CBI) or other regulators that subject them to certain rules regarding minimum net capital. Failure to meet these requirements could result in adverse consequences to us, including additional reporting requirements, or interruption of our business. At March 31, 2024, these subsidiaries were in compliance with all minimum net capital requirements.

Balance Sheet
Cash and cash equivalents consist of cash in banks and money market fund investments. Investments consist primarily of investments in our sponsored funds. CIP represent investment products for which we provide investment
27

management services and where we have either a controlling financial interest or are considered the primary beneficiary of an investment product that is considered a variable interest entity.

Operating Cash Flow
Net cash used in operating activities of $34.5 million for the three months ended March 31, 2024 decreased by $8.4 million from net cash used in operating activities of $43.0 million for the same period in the prior year primarily due to an increase in cash from higher net income and an increase of $17.1 million in net sales of investments by CIP in the current year period partially offset by an increase in payments in incentive compensation in the current year.

Investing Cash Flow
Cash flows from investing activities consist primarily of capital expenditures and other investing activities related to our business operations. Net cash used in investing activities of $2.5 million for the three months ended March 31, 2024 decreased by $10.7 million from net cash used in investing activities of $13.1 million for the same period in the prior year primarily due to cash paid for an equity method investment in the prior year period that did not reoccur in the current year period.

Financing Cash Flow
Cash flows from financing activities consist primarily of transactions related to our common shares, issuance and repayment of debt by us and CIP, payments of contingent consideration and purchases and sales of noncontrolling interests. Net cash used in financing activities of $56.1 million for the three months ended March 31, 2024 decreased by $58.9 million from net cash used in investing activities of $115.1 million for the same period in the prior year primarily due to a $43.4 million decrease in the repayment on borrowings of CIP and a $16.5 million increase in net contributions from noncontrolling interests.

Credit Agreement
The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026. The Company repaid $0.7 million outstanding under the Term Loan during the three months ended March 31, 2024 and had $258.1 million outstanding under the Term Loan at March 31, 2024. In accordance with ASC 835, Interest, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March 31, 2024.

Critical Accounting Policies and Estimates
Our financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates. Actual results will vary from these estimates. A discussion of our critical accounting policies and estimates is included in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2023 Annual Report on Form 10-K. A complete description of our significant accounting policies is included in our 2023 Annual Report on Form 10-K. There were no material changes in our critical accounting policies and estimates in the three months ended March 31, 2024.

Recently Issued Accounting Pronouncements
For a discussion of accounting standards, see Note 2 in our condensed consolidated financial statements. 


Item 3.    Quantitative and Qualitative Disclosures About Market Risk
The Company is primarily exposed to market risk associated with unfavorable movements in interest rates and securities prices. During the three months ended March 31, 2024, there were no material changes to the information contained in Part II, Item 7A of the Company's 2023 Annual Report on Form 10-K.


Item 4.    Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as
28

appropriate, to allow timely decisions regarding required disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2024, the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


PART II – OTHER INFORMATION
 
Item 1.    Legal Proceedings
The information set forth in response to Item 103 of Regulation S-K under "Legal Proceedings" is incorporated by reference from Part I, Financial Information Item 1. "Financial Statements" Note 14 "Commitments and Contingencies" of this Quarterly Report on Form 10-Q.


Item 1A.    Risk Factors    
There have been no material changes to the Company’s risk factors from those previously reported in our 2023 Annual Report on Form 10-K.


Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
An aggregate of 5,680,045 shares of our common stock have been authorized to be repurchased under a share repurchase program since it was initially approved in 2010 by our Board of Directors. As of March 31, 2024, 583,437 shares remained available for repurchase. Under the terms of the program, we may repurchase shares of our common stock from time to time at our discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price, prevailing market and business conditions, tax and other financial considerations. The program, which has no specified term, may be suspended or terminated at any time.

The following table sets forth information regarding our share repurchases in each month during the quarter ended March 31, 2024.
PeriodTotal number of shares purchasedAverage price paid per share (1)Total number of shares purchased as part of publicly announced plans or programs (2)Maximum number of shares that may yet be purchased under the plans or programs (2)
January 1-31, 2024— $— — 604,545 
February 1-29, 20249,634 $232.77 9,634 594,911 
March 1-31, 202411,474 $240.26 11,474 583,437 
Total21,108 21,108 
(1)Average price paid per share is calculated on a settlement basis and excludes commissions and taxes.
(2)The share repurchases above were completed pursuant to a program announced in the fourth quarter of 2010 and most recently expanded in May 2022. This repurchase program is not subject to an expiration date.


29



Item 5.    Other Information
During the three months ended March 31, 2024, none of the Company's directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended), adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

Item 6.    Exhibits
Exhibit
Number
Description
Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of the Registrant’s Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)


30

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: May 8, 2024
VIRTUS INVESTMENT PARTNERS, INC.
(Registrant)
By:/s/ Michael A. Angerthal
Michael A. Angerthal
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

31

Exhibit 31.1
CERTIFICATION UNDER SECTION 302
I, George R. Aylward, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 8, 2024
 
/S/     GEORGE R. AYLWARD
George R. Aylward
President, Chief Executive Officer and Director
(Principal Executive Officer)



Exhibit 31.2
CERTIFICATION UNDER SECTION 302
I, Michael A. Angerthal, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 8, 2024
 
/S/     MICHAEL A. ANGERTHAL
Michael A. Angerthal
Executive Vice President, Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)



Exhibit 32.1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc. (the “Company”) for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 8, 2024
 
/S/    GEORGE R. AYLWARD
George R. Aylward
President, Chief Executive Officer and Director
(Principal Executive Officer)
 
/S/    MICHAEL A. ANGERTHAL
Michael A. Angerthal
Executive Vice President, Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)


v3.24.1.u1
Cover - shares
3 Months Ended
Mar. 31, 2024
May 01, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-10994  
Entity Registrant Name VIRTUS INVESTMENT PARTNERS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 26-3962811  
Entity Address, Address Line One One Financial Plaza  
Entity Address, City or Town Hartford  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06103  
City Area Code 800  
Local Phone Number 248-7971  
Title of 12(b) Security Common Stock, $0.01 par value  
Trading Symbol VRTS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   7,127,881
Amendment Flag false  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000883237  
Current Fiscal Year End Date --12-31  
v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets:    
Accounts receivable, net $ 116,387 $ 109,076
Furniture, equipment and leasehold improvements, net 26,088 26,216
Intangible assets, net 416,784 432,119
Goodwill 397,098 397,098
Deferred taxes, net 23,974 25,024
Total assets 3,548,125 3,678,629
Liabilities:    
Accrued compensation and benefits 95,591 200,837
Accounts payable and accrued liabilities 44,282 38,756
Dividends payable 16,553 17,291
Contingent consideration 66,704 90,938
Debt 253,008 253,412
Other liabilities 67,460 91,471
Total liabilities 2,556,937 2,705,471
Commitments and Contingencies (Note 14)
Redeemable noncontrolling interests 115,185 104,869
Equity attributable to Virtus Investment Partners, Inc.:    
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,224,489 shares issued and 7,127,881 shares outstanding at March 31, 2024; and 12,163,228 shares issued and 7,087,728 shares outstanding at December 31, 2023 122 122
Additional paid-in capital 1,298,157 1,300,999
Retained earnings (accumulated deficit) 223,023 207,356
Accumulated other comprehensive income (loss) (187) (87)
Treasury stock, at cost, 5,096,608 and 5,075,500 shares at March 31, 2024 and December 31, 2023, respectively (649,463) (644,464)
Total equity attributable to Virtus Investment Partners, Inc. 871,652 863,926
Total equity 876,003 868,289
Total liabilities and equity 3,548,125 3,678,629
Consolidated Entity excluding Consolidated Investment Products    
Assets:    
Cash and cash equivalents 123,880 239,602
Investments 127,448 132,696
Other assets 79,596 89,438
Consolidated Investment Products    
Assets:    
Cash and cash equivalents 123,030 100,732
Investments 2,081,225 2,082,713
Cash pledged or on deposit of CIP 767 680
Other assets 31,848 43,235
Liabilities:    
Notes payable of CIP 1,922,051 1,922,243
Securities purchased payable and other liabilities of CIP 91,288 90,523
Equity attributable to Virtus Investment Partners, Inc.:    
Noncontrolling interests $ 4,351 $ 4,363
v3.24.1.u1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, shares issued (in shares) 12,224,489 12,163,228
Common stock, shares outstanding (in shares) 7,127,881 7,087,728
Treasury stock, shares (in shares) 5,096,608 5,075,500
v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Revenues $ 222,042 $ 197,874
Operating Expenses    
Employment expenses 115,163 98,614
Distribution and other asset-based expenses 24,348 23,715
Restructuring expense 797 0
Depreciation expense 2,028 1,145
Amortization expense 15,335 14,391
Total operating expenses 189,736 169,295
Operating Income (Loss) 32,306 28,579
Other Income (Expense)    
Other income (expense), net 550 (343)
Total other income (expense), net 5,501 4,923
Interest Income (Expense)    
Total interest income (expense), net 8,891 9,844
Income (Loss) Before Income Taxes 46,698 43,346
Income tax expense (benefit) 8,831 8,703
Net Income (Loss) 37,867 34,643
Noncontrolling interests (8,009) 3,981
Net Income (Loss) Attributable to Virtus Investment Partners, Inc. $ 29,858 $ 38,624
Earnings (Loss) per Share—Basic (in dollars per share) $ 4.19 $ 5.33
Earnings (Loss) per Share—Diluted (in dollars per share) $ 4.10 $ 5.21
Weighted Average Shares Outstanding—Basic (in shares) 7,119 7,245
Weighted Average Shares Outstanding—Diluted (in shares) 7,287 7,410
Consolidated Entity excluding Consolidated Investment Products    
Operating Expenses    
Other operating expenses $ 31,375 $ 30,730
Other Income (Expense)    
Realized and unrealized gain (loss) on investments, net 3,416 2,670
Interest Income (Expense)    
Interest expense (5,681) (5,005)
Interest and dividend income 3,469 3,238
Consolidated Investment Products    
Operating Expenses    
Other operating expenses 690 700
Other Income (Expense)    
Realized and unrealized gain (loss) on investments, net 1,535 2,596
Interest Income (Expense)    
Interest expense (40,012) (35,203)
Interest and dividend income 51,115 46,814
Investment management fees    
Revenues    
Revenues 188,360 164,478
Distribution and service fees    
Revenues    
Revenues 14,030 14,153
Administration and shareholder service fees    
Revenues    
Revenues 18,678 18,359
Other income and fees    
Revenues    
Revenues $ 974 $ 884
v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net Income (Loss) $ 37,867 $ 34,643
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustment, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively (100) 99
Other comprehensive income (loss) (100) 99
Comprehensive income (loss) 37,767 34,742
Comprehensive (income) loss attributable to noncontrolling interests (8,009) 3,981
Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc. $ 29,758 $ 38,723
v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Foreign currency translation adjustment, tax $ 36 $ (35)
v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income (loss) $ 37,867 $ 34,643
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation expense, intangible asset and other amortization 18,164 16,410
Stock-based compensation 6,831 5,749
Equity in earnings of equity method investments (498) 554
Deferred taxes, net 1,086 1,441
Changes in operating assets and liabilities:    
Sales (purchases) of investments, net 5,987 5,217
Accounts receivable, net and other assets (341) 8,725
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities (120,631) (115,514)
Operating activities of consolidated investment products ("CIP"):    
Net cash provided by (used in) operating activities (34,528) (42,959)
Cash Flows from Investing Activities:    
Capital expenditures (1,923) (1,448)
Purchase of equity method investment 0 (11,645)
Net cash provided by (used in) investing activities (2,460) (13,145)
Cash Flows from Financing Activities:    
Repayments on credit agreement (688) (688)
Common stock dividends paid (14,929) (14,083)
Repurchase of common shares (5,000) 0
Payment of contingent consideration (24,234) (27,179)
Taxes paid related to net share settlement of restricted stock units (9,854) (12,209)
Affiliate equity sales (purchases) (419) 0
Net contributions from (distributions to) noncontrolling interests 16,772 294
Net cash provided by (used in) financing activities (56,146) (115,078)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (203) 180
Net increase (decrease) in cash, cash equivalents and restricted cash (93,337) (171,002)
Cash, cash equivalents and restricted cash, beginning of period 341,014 589,179
Cash, cash equivalents and restricted cash, end of period 247,677 418,177
Non-Cash Financing Activities:    
Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net (13,624) (3,447)
Common stock dividends payable 13,467 11,850
Reconciliation of cash, cash equivalents and restricted cash    
Cash, cash equivalents and restricted cash at end of period 247,677 418,177
Consolidated Entity excluding Consolidated Investment Products    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Realized and unrealized (gains) losses on investments, net (3,393) (2,670)
Operating activities of consolidated investment products ("CIP"):    
Realized and unrealized (gains) losses on investments of CIP, net (3,393) (2,670)
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 123,880  
Consolidated Investment Products    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Realized and unrealized (gains) losses on investments, net (3,732) (3,844)
Operating activities of consolidated investment products ("CIP"):    
Realized and unrealized (gains) losses on investments of CIP, net (3,732) (3,844)
Purchases of investments by CIP (304,516) (320,808)
Sales of investments by CIP 323,720 323,380
Net proceeds (purchases) of short-term investments and securities sold short by CIP 206 (218)
Change in other assets and liabilities of CIP 4,722 3,976
Cash Flows from Investing Activities:    
Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net (537) (52)
Cash Flows from Financing Activities:    
Payments on borrowings by CIP (17,794) $ (61,213)
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 123,030  
Cash pledged or on deposit of CIP $ 767  
v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Total Attributed To Virtus Investment Partners, Inc.
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Non- controlling Interests
Balance at beginning of period, common stock (in shares) at Dec. 31, 2022     7,181,554          
Balance at beginning of period at Dec. 31, 2022 $ 822,936 $ 817,019 $ 120 $ 1,286,244 $ 130,261 $ (358) $ (599,248) $ 5,917
Balance at beginning of period, treasury stock (in shares) at Dec. 31, 2022             4,851,693  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 39,389 38,624     38,624     765
Foreign currency translation adjustments 99 99       99    
Net subscriptions (redemptions) and other (300) 0   0       (300)
Cash dividends declared, common (13,093) (13,093)     (13,093)      
Issuance of common shares related to employee stock transactions (in shares)     106,840          
Issuance of common shares related to employee stock transactions 0 0 $ 1 (1)        
Taxes paid on stock-based compensation (12,209) (12,209)   (12,209)        
Stock-based compensation 7,475 7,475   7,475        
Balance at end of period, common stock (in shares) at Mar. 31, 2023     7,288,394          
Balance at end of period at Mar. 31, 2023 844,297 837,915 $ 121 1,281,509 155,792 (259) $ (599,248) 6,382
Balance at end of period, treasury stock (in shares) at Mar. 31, 2023             4,851,693  
Balance at Dec. 31, 2022 113,718              
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]                
Net income (loss) (4,746)              
Net subscriptions (redemptions) and other (2,342)              
Balance at Mar. 31, 2023 $ 106,630              
Balance at beginning of period, common stock (in shares) at Dec. 31, 2023 12,163,228   7,087,728          
Balance at beginning of period at Dec. 31, 2023 $ 868,289 863,926 $ 122 1,300,999 207,356 (87) $ (644,464) 4,363
Balance at beginning of period, treasury stock (in shares) at Dec. 31, 2023 5,075,500           5,075,500  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 30,249 29,858     29,858     391
Foreign currency translation adjustments (100) (100)       (100)    
Net subscriptions (redemptions) and other (403) 0   0       (403)
Cash dividends declared, common (14,191) (14,191)     (14,191)      
Repurchases of common shares (in shares)     21,108       21,108  
Repurchases of common shares (4,999) (4,999)         $ (4,999)  
Issuance of common shares related to employee stock transactions (in shares)     61,261          
Issuance of common shares related to employee stock transactions 0 0            
Taxes paid on stock-based compensation (9,852) (9,852)   (9,852)        
Stock-based compensation $ 7,010 7,010   7,010        
Balance at end of period, common stock (in shares) at Mar. 31, 2024 12,224,489   7,127,881          
Balance at end of period at Mar. 31, 2024 $ 876,003 $ 871,652 $ 122 $ 1,298,157 $ 223,023 $ (187) $ (649,463) $ 4,351
Balance at end of period, treasury stock (in shares) at Mar. 31, 2024 5,096,608           5,096,608  
Balance at Dec. 31, 2023 $ 104,869              
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]                
Net income (loss) 7,618              
Net subscriptions (redemptions) and other 2,698              
Balance at Mar. 31, 2024 $ 115,185              
v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares
3 Months Ended
Feb. 21, 2024
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared per common share (in dollars per share) $ 1.90 $ 1.90 $ 1.65
v3.24.1.u1
Organization and Business
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Business Organization and Business
Virtus Investment Partners, Inc. (the "Company," "we," "us," "our" or "Virtus"), a Delaware corporation, operates in the investment management industry through its subsidiaries.

The Company provides investment management and related services to institutions and individuals. The Company's investment strategies are offered to institutional clients through institutional separate and commingled accounts, including structured products. The Company’s retail investment management services are provided to individuals through products consisting of: mutual funds registered pursuant to the Investment Company Act of 1940, as amended ("U.S. retail funds"); Undertaking for Collective Investment in Transferable Securities and Qualifying Investor Funds (collectively, "global funds") and collectively with U.S. retail funds, variable insurance funds, and exchange-traded funds ("ETFs"), (the "open-end funds"); closed-end funds (collectively, with open-end funds, the "funds"); and retail separate accounts that include intermediary-sold and private client accounts. The Company also provides subadvisory services to other investment advisers.
v3.24.1.u1
Basis of Presentation and Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Significant Accounting Policies Basis of Presentation and Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company’s financial condition and results of operations. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC"). The Company’s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.

New Accounting Standards Not Yet Implemented
In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280). This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards. This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.
v3.24.1.u1
Revenues
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers. Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed. The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance. Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.

Investment Management Fees by Source    
The following table summarizes investment management fees by source:
 Three Months Ended
March 31,
(in thousands)20242023
Investment management fees
Open-end funds$78,680 $71,266 
Closed-end funds14,394 14,678 
Retail separate accounts48,981 40,079 
Institutional accounts46,305 38,455 
Total investment management fees$188,360 $164,478 
v3.24.1.u1
Acquisitions
3 Months Ended
Mar. 31, 2024
Business Combination and Asset Acquisition [Abstract]  
Acquisitions Acquisitions
AlphaSimplex Group, LLC
On April 1, 2023, the Company completed the acquisition of AlphaSimplex Group, LLC ("AlphaSimplex"), which was accounted for in accordance with Accounting Standards Codification ("ASC") 805, Business Combinations ("ASC 805"). The total purchase price paid of $113.4 million was allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the date of the acquisition. Goodwill of $48.3 million and intangible assets of $55.4 million were recorded for the acquisition.
v3.24.1.u1
Intangible Assets, Net
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net Intangible Assets, Net
Below is a summary of intangible assets, net:
Definite-LivedIndefinite-LivedTotal
(in thousands)Gross Book ValueAccumulated AmortizationNet Book ValueNet Book ValueNet Book Value
Balances at December 31, 2023$806,655 $(416,834)$389,821 $42,298 $432,119 
Intangible amortization— (15,335)(15,335)— (15,335)
Balances at March 31, 2024$806,655 $(432,169)$374,486 $42,298 $416,784 
Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows:
Fiscal Year
Amount
(in thousands)
Remainder of 2024$40,964 
202551,532 
202650,552 
202747,450 
202841,787 
2029 and thereafter142,201 
Total$374,486 
v3.24.1.u1
Investments
3 Months Ended
Mar. 31, 2024
Schedule of Investments [Abstract]  
Investments Investments
Investments consist primarily of investments in the Company's sponsored products. The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March 31, 2024 and December 31, 2023 were as follows:
(in thousands)March 31,
2024
December 31, 2023
Investment securities - fair value$90,497 $97,304 
Equity method investments (1)23,208 22,710 
Nonqualified retirement plan assets13,743 12,682 
Total investments$127,448 $132,696 
(1)    The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.

Investment Securities - fair value
Investment securities - fair value consist of investments in the Company's sponsored funds and separately managed accounts. The composition of the Company’s investment securities - fair value was as follows:
March 31, 2024December 31, 2023
(in thousands)CostFair ValueCostFair Value
Investment Securities - fair value
Sponsored funds$69,067 $69,514 $80,794 $77,433 
Equity securities16,875 20,983 16,353 19,871 
Total investment securities - fair value$85,942 $90,497 $97,147 $97,304 
For the three months ended March 31, 2024 and 2023, the Company recognized net realized losses of $0.4 million and net realized gains $1.3 million, respectively, related to its investment securities - fair value.
v3.24.1.u1
Fair Value Measurements
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
March 31, 2024  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$92,458 $— $— $92,458 
Investment securities - fair value
Sponsored funds69,514 — — 69,514 
Equity securities20,983 — — 20,983 
Nonqualified retirement plan assets13,743 — — 13,743 
Total assets measured at fair value$196,698 $ $ $196,698 
Liabilities
Contingent consideration$— $— $41,708 $41,708 
Total liabilities measured at fair value$ $ $41,708 $41,708 
December 31, 2023  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$197,240 $— $— $197,240 
Investment securities - fair value
Sponsored funds77,433 — — 77,433 
Equity securities19,871 — — 19,871 
Nonqualified retirement plan assets12,682 — — 12,682 
Total assets measured at fair value$307,226 $ $ $307,226 
Liabilities
Contingent consideration$— $— $56,200 $56,200 
Total liabilities measured at fair value$ $ $56,200 $56,200 
The following is a discussion of the valuation methodologies used for the Company’s assets measured at fair value:

Cash equivalents represent investments in money market funds. Cash investments in money market funds are valued using published net asset values and are classified as Level 1.

Sponsored funds represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager. The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1. The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.

Equity securities represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.

Nonqualified retirement plan assets represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.

Contingent consideration represents liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ") transactions . The continent consideration related to the WCM transaction as of March 31, 2024 was $11.1 million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates. The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%). The NFJ contingent consideration liability as of March 31, 2024 was $30.6 million and represents the fair value of the projected future revenue participation payments. The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets. The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%). These liabilities are categorized as Level 3.
The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:
Three Months Ended
March 31,
(in thousands)20242023
Contingent consideration, beginning of period$56,200 $78,100 
Reduction for payments made(14,492)(16,390)
Contingent consideration, end of period$41,708 $61,710 

Cash, accounts receivable, accounts payable and accrued liabilities equal or approximate fair value based on the short-term nature of these instruments.
v3.24.1.u1
Equity Transactions
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Equity Transactions Equity Transactions
Dividends Declared
On February 21, 2024, the Company declared a quarterly cash dividend of $1.90 per common share to be paid on May 15, 2024 to shareholders of record at the close of business on April 30, 2024.

Common Stock Repurchases
During the three months ended March 31, 2024, the Company repurchased 21,108 common shares at a weighted average price of $236.84 per share for a total cost, including fees and expenses, of $5.0 million under its share repurchase program. As of March 31, 2024, 583,437 shares remained available for repurchase. Under the terms of the program, the Company may repurchase shares of its common stock from time to time at its discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price and prevailing market and business conditions. The program, which has no specified term, may be suspended or terminated at any time.
v3.24.1.u1
Accumulated Other Comprehensive Income (Loss)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive income (loss) were as follows:
Three Months Ended
March 31,
(in thousands)20242023
Balance at beginning of period$(87)$(358)
Net current-period other comprehensive income (loss) (1)(100)99 
Balance at end of period$(187)$(259)
(1)     Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively.
v3.24.1.u1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Equity-based awards, including restricted stock units ("RSUs"), performance stock units ("PSUs"), stock options and unrestricted shares of common stock, may be granted to officers, employees and directors of the Company pursuant to the Company's Omnibus Incentive and Equity Plan (the "Omnibus Plan"). At March 31, 2024, 375,169 shares of common stock remained available for issuance of the 3,370,000 shares that are authorized for issuance under the Omnibus Plan.     
Stock-based compensation expense is summarized as follows:
Three Months Ended March 31,
(in thousands)20242023
Stock-based compensation expense$6,831 $5,749 
Restricted Stock Units
Each RSU entitles the holder to one share of common stock when the restriction expires. RSUs may be time-vested or performance-contingent PSUs that convert into RSUs after performance measurement is complete and generally vest in one to three years. Shares that are issued upon vesting are newly issued shares from the Omnibus Plan and are not issued from treasury stock.

RSU activity, inclusive of PSUs, for the three months ended March 31, 2024 is summarized as follows: 
Number
of Shares
Weighted Average
Grant Date
Fair Value
Outstanding at December 31, 2023344,717 $204.48 
Granted108,658 $235.14 
Forfeited(8,333)$261.65 
Settled(103,849)$229.92 
Outstanding at March 31, 2024341,193 $205.10 

For the three months ended March 31, 2024 and 2023, a total of 42,588 and 70,716 RSUs, respectively, were withheld by the Company as a result of net share settlements to settle minimum employee tax withholding obligations and for which the Company paid $9.9 million and $12.2 million respectively, in minimum employee tax withholding obligations. These net share settlements had the effect of share repurchases by the Company as they reduced the number of shares that would have otherwise been issued as a result of the vesting.

During the three months ended March 31, 2024 and 2023, the Company granted 26,733 and 44,291 PSUs, respectively, that contain performance-based metrics in addition to a service condition. Compensation expense for PSUs is generally recognized over a three-year service period based upon the value determined using a combination of (i) the intrinsic value method for awards that contain a performance metric that represents a "performance condition" in accordance with ASC 718, Stock Compensation ("ASC 718") and (ii) the Monte Carlo simulation valuation model for awards that contain a "market condition" performance metric under ASC 718. Compensation expense for PSU awards that contain a market condition is fixed at the date of grant and will not be adjusted in future periods based upon the achievement of the market condition. Compensation expense for PSU awards with a performance condition is recorded each period based upon a probability assessment of the expected outcome of the performance metric with a final adjustment upon measurement at the end of the performance period.

As of March 31, 2024, unamortized stock-based compensation expense for unvested RSUs and PSUs was $45.5 million with a weighted-average remaining contractual life of 1.6 years.
v3.24.1.u1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
Earnings (loss) per share ("EPS") is calculated in accordance with ASC 260, Earnings per Share. Basic EPS is computed by dividing net income (loss) attributable to Virtus Investment Partners, Inc. by the weighted-average number of common shares outstanding for the period, excluding dilution for potential common stock issuances. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, including shares issuable upon the vesting of RSUs and stock option exercises using the treasury stock method, as determined under the if-converted method.
The computation of basic and diluted EPS is as follows: 
 Three Months Ended March 31,
(in thousands, except per share amounts)20242023
Net Income (Loss)$37,867 $34,643 
Noncontrolling interests(8,009)3,981 
Net Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,858 $38,624 
Shares:
Basic: Weighted-average number of shares outstanding7,119 7,245 
Plus: Incremental shares from assumed conversion of dilutive instruments168 165 
Diluted: Weighted-average number of shares outstanding7,287 7,410 
Earnings (Loss) per Share—Basic$4.19 $5.33 
Earnings (Loss) per Share—Diluted$4.10 $5.21 

The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.
 Three Months Ended March 31,
(in thousands)20242023
Restricted stock units40 
Total anti-dilutive securities1 40 
v3.24.1.u1
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
In calculating the provision for income taxes, the Company uses an estimate of the annual effective tax rate based upon the facts and circumstances at each interim period. On a quarterly basis, the estimated annual effective tax rate is adjusted, as appropriate, based upon changes in facts and circumstances, if any, compared to those forecasted at the beginning of the fiscal year and at each interim period thereafter.

The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March 31, 2024 and 2023, respectively. The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain Company investments.
v3.24.1.u1
Debt
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
Credit Agreement
The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026. The Company repaid $0.7 million outstanding under the Term Loan during the three months ended March 31, 2024 and had $258.1 million outstanding under the Term Loan at March 31, 2024. In accordance with ASC 835, Interest, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March 31, 2024.
v3.24.1.u1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Matters
The Company is involved from time to time in litigation and arbitration, as well as examinations, inquiries and investigations by various regulatory bodies, involving its compliance with, among other things, securities laws, client investment guidelines, laws governing the activities of broker-dealers and other laws and regulations affecting its products and other activities.
The Company records a liability when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on information currently available, available insurance coverage, indemnities and established reserves, the Company believes that the outcomes of its legal and regulatory proceedings are not likely, either individually or in the aggregate, to have a material adverse effect on the Company's results of operations, cash flows or its consolidated financial condition. However, in the event of unexpected subsequent developments, and given the inherent unpredictability of these legal and regulatory matters, the Company can provide no assurance that its assessment of any legal matter will reflect the ultimate outcome, and an adverse outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.
v3.24.1.u1
Redeemable Noncontrolling Interests
3 Months Ended
Mar. 31, 2024
Noncontrolling Interest [Abstract]  
Redeemable Noncontrolling Interests Redeemable Noncontrolling Interests
Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate. Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value. The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement. The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests. The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity. These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.

Redeemable noncontrolling interests for the three months ended March 31, 2024 included the following amounts:
(in thousands)CIPAffiliate Noncontrolling InterestsTotal
Balances at December 31, 2023$30,643 $74,226 $104,869 
Net income (loss) attributable to noncontrolling interests1,429 1,829 3,258 
Changes in redemption value (1)— 4,360 4,360 
Total net income (loss) attributable to noncontrolling interests1,429 6,189 7,618 
Affiliate equity sales (purchases)— (419)(419)
Net subscriptions (redemptions) and other3,117 — 3,117 
Balances at March 31, 2024$35,189 $79,996 $115,185 
(1)     Relates to noncontrolling interests redeemable at other than fair value.
v3.24.1.u1
Consolidation
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidation Consolidation
The condensed consolidated financial statements include the accounts of the Company, its subsidiaries and investment products that are consolidated. A voting interest entity ("VOE") is consolidated when the Company is considered to have a controlling financial interest, which is typically present when the Company owns a majority of the voting interest in an entity or otherwise has the power to govern the financial and operating policies of the entity.

The Company evaluates any variable interest entity ("VIE") in which the Company has a variable interest for consolidation. A VIE is an entity in which either (i) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support, or (ii) where as a group, the holders of the equity investment at risk do not possess any one of the following: (a) the power through voting or similar rights to direct the activities that most significantly impact the entity's economic performance, (b) the obligation to absorb expected losses or the right to receive expected residual returns of the entity, or (c) proportionate voting and economic interests and where substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately fewer voting rights. If an entity has any of these characteristics, it is considered a VIE and is required to be consolidated by its primary beneficiary. The primary beneficiary is the entity that has both the power to direct the activities that most significantly impact the VIE's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.
In the normal course of its business, the Company sponsors various investment products, some of which are consolidated by the Company. CIP includes both VOEs, made up primarily of U.S. retail funds and ETFs in which the Company holds a controlling financial interest, and VIEs, which consist of collateralized loan obligations ("CLO") and certain global and private funds ("GF") of which the Company is considered the primary beneficiary. The consolidation and deconsolidation of these investment products have no impact on the Company's net income (loss). The Company's risk with respect to these investment products is limited to its beneficial interests in these products. The Company has no right to the benefits from, and does not bear the risks associated with, these investment products beyond the Company's investments in, and fees generated from, these products.

The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023:
As of
 March 31, 2024December 31, 2023
VOEsVIEsVOEsVIEs
(in thousands)CLOs GFsCLOsGFs
Cash and cash equivalents$1,271 $119,914 $2,612 $1,223 $98,101 $2,088 
Investments40,591 1,962,697 77,937 30,985 1,972,342 79,386 
Other assets616 30,064 1,168 174 41,985 1,076 
Notes payable— (1,922,051)— — (1,922,243)— 
Securities purchased payable and other liabilities(1,019)(88,270)(1,999)(740)(89,167)(616)
Noncontrolling interests(12,311)(4,351)(22,878)(7,316)(4,363)(23,327)
Net interests in CIP$29,148 $98,003 $56,840 $24,326 $96,655 $58,607 

Consolidated CLOs
The majority of the Company's CIP that are VIEs are CLOs. The financial information of certain CLOs is included on the Company's condensed consolidated financial statements on a one-month lag based upon the availability of their financial information. A majority-owned consolidated private fund, whose primary purpose is to invest in CLOs for which the Company serves as the collateral manager, is also included. At March 31, 2024, the Company consolidated seven CLOs.

Investments of CLOs
The CLOs held investments of $2.0 billion at March 31, 2024, consisting of bank loan investments that comprise the majority of the CLOs' portfolio asset collateral and are senior secured corporate loans across a variety of industries. These bank loan investments mature at various dates between 2024 and 2032 and generally pay interest at SOFR plus a spread.

Notes Payable of CLOs
The CLOs held notes payable with a total value, at par, of $2.1 billion at March 31, 2024, consisting of senior secured floating rate notes payable with a par value of $1.9 billion and subordinated notes with a par value of $215.1 million. These note obligations bear interest at variable rates based on SOFR plus a pre-defined spread.

The Company's beneficial interests and maximum exposure to loss related to these consolidated CLOs is limited to (i) ownership in the subordinated notes and (ii) accrued management fees. The secured notes of the consolidated CLOs have contractual recourse only to the related assets of the CLO and are classified as financial liabilities. Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, Consolidation (Topic 810) ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March 31, 2024, as shown in the table below:
(in thousands)
Subordinated notes$96,416 
Accrued investment management fees1,587 
Total Beneficial Interests$98,003 
The following table represents income and expenses of the consolidated CLOs included on the Company’s Condensed Consolidated Statements of Operations for the period indicated:
Three Months Ended March 31, 2024
(in thousands)
Income:
Realized and unrealized gain (loss), net$
Interest income49,280 
Total Income49,281 
Expenses:
Other operating expenses499 
Interest expense40,011 
Total Expense40,510 
Noncontrolling interests(391)
Net Income (Loss) Attributable to CLOs$8,380 

The following table represents the Company’s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:
Three Months Ended March 31, 2024
(in thousands)
Distributions received and unrealized gains (losses) on the subordinated notes held by the Company$6,083 
Investment management fees2,297 
Total Economic Interests$8,380 

Fair Value Measurements of CIP
The assets and liabilities of CIP measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
As of March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$119,914 $— $— $119,914 
Debt investments— 2,003,579 47,551 2,051,130 
Equity investments 29,469 384 242 30,095 
Total assets measured at fair value$149,383 $2,003,963 $47,793 $2,201,139 
Liabilities
Notes payable$— $1,922,051 $— $1,922,051 
Short sales485 — — 485 
Total liabilities measured at fair value$485 $1,922,051 $ $1,922,536 
As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$98,101 $— $— $98,101 
Debt investments241 2,012,760 36,616 2,049,617 
Equity investments32,642 446 33,096 
Total assets measured at fair value$130,984 $2,012,768 $37,062 $2,180,814 
Liabilities
Notes payable$— $1,922,243 $— $1,922,243 
Short sales518 — — 518 
Total liabilities measured at fair value$518 $1,922,243 $ $1,922,761 

The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company’s CIP measured at fair value:

Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.

Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service. Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities. Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service. Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.

Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security. These securities are valued using unadjusted prices from an independent pricing service.

Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline. Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.

Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13. Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services. The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.

The securities purchased payable at March 31, 2024 and December 31, 2023 approximated fair value due to the short-term nature of the instruments.
The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:
 Three Months Ended March 31,
 (in thousands)
20242023
Balance at beginning of period$37,062 $43,581 
Realized and unrealized gains (losses), net(324)111 
Purchases— 
Sales(14,625)(7,195)
Transfers to Level 2(13,468)(35,747)
Transfers from Level 239,148 9,904 
Balance at end of period (1)$47,793 $10,658 
(1)The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment. Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.

Nonconsolidated VIEs
The Company serves as the collateral manager for other CLOs that are not consolidated. The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees. The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length.
    
The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance. At March 31, 2024, the carrying value and maximum risk of loss related to the Company's interest in these VIEs was $29.1 million.
v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.u1
Basis of Presentation and Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company’s financial condition and results of operations. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC"). The Company’s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.
New Accounting Standards Not Yet Implemented
New Accounting Standards Not Yet Implemented
In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280). This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards. This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification. This standard is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.
Revenue Recognition
The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers. Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed. The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance. Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.
Fair Value Measurements
The following is a discussion of the valuation methodologies used for the Company’s assets measured at fair value:

Cash equivalents represent investments in money market funds. Cash investments in money market funds are valued using published net asset values and are classified as Level 1.

Sponsored funds represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager. The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1. The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.

Equity securities represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.

Nonqualified retirement plan assets represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.

Contingent consideration represents liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ") transactions . The continent consideration related to the WCM transaction as of March 31, 2024 was $11.1 million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates. The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%). The NFJ contingent consideration liability as of March 31, 2024 was $30.6 million and represents the fair value of the projected future revenue participation payments. The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets. The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm. The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%). These liabilities are categorized as Level 3.
The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company’s CIP measured at fair value:

Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.

Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service. Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities. Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service. Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.

Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security. These securities are valued using unadjusted prices from an independent pricing service.

Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline. Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.

Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13. Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services. The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.
Noncontrolling Interest Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate. Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value. The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement. The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests. The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity. These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.
Nonconsolidated VIEs
Nonconsolidated VIEs
The Company serves as the collateral manager for other CLOs that are not consolidated. The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees. The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length.
    
The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.
v3.24.1.u1
Revenues (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Disaggregation of Revenue
The following table summarizes investment management fees by source:
 Three Months Ended
March 31,
(in thousands)20242023
Investment management fees
Open-end funds$78,680 $71,266 
Closed-end funds14,394 14,678 
Retail separate accounts48,981 40,079 
Institutional accounts46,305 38,455 
Total investment management fees$188,360 $164,478 
v3.24.1.u1
Intangible Assets, Net (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill and Intangible Assets, Net
Below is a summary of intangible assets, net:
Definite-LivedIndefinite-LivedTotal
(in thousands)Gross Book ValueAccumulated AmortizationNet Book ValueNet Book ValueNet Book Value
Balances at December 31, 2023$806,655 $(416,834)$389,821 $42,298 $432,119 
Intangible amortization— (15,335)(15,335)— (15,335)
Balances at March 31, 2024$806,655 $(432,169)$374,486 $42,298 $416,784 
Schedule of Estimated Amortization Expense of Intangible Assets Succeeding Years
Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows:
Fiscal Year
Amount
(in thousands)
Remainder of 2024$40,964 
202551,532 
202650,552 
202747,450 
202841,787 
2029 and thereafter142,201 
Total$374,486 
v3.24.1.u1
Investments (Tables)
3 Months Ended
Mar. 31, 2024
Schedule of Investments [Abstract]  
Schedule of Investments The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March 31, 2024 and December 31, 2023 were as follows:
(in thousands)March 31,
2024
December 31, 2023
Investment securities - fair value$90,497 $97,304 
Equity method investments (1)23,208 22,710 
Nonqualified retirement plan assets13,743 12,682 
Total investments$127,448 $132,696 
(1)    The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.
Schedule of Marketable Securities The composition of the Company’s investment securities - fair value was as follows:
March 31, 2024December 31, 2023
(in thousands)CostFair ValueCostFair Value
Investment Securities - fair value
Sponsored funds$69,067 $69,514 $80,794 $77,433 
Equity securities16,875 20,983 16,353 19,871 
Total investment securities - fair value$85,942 $90,497 $97,147 $97,304 
v3.24.1.u1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
March 31, 2024  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$92,458 $— $— $92,458 
Investment securities - fair value
Sponsored funds69,514 — — 69,514 
Equity securities20,983 — — 20,983 
Nonqualified retirement plan assets13,743 — — 13,743 
Total assets measured at fair value$196,698 $ $ $196,698 
Liabilities
Contingent consideration$— $— $41,708 $41,708 
Total liabilities measured at fair value$ $ $41,708 $41,708 
December 31, 2023  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$197,240 $— $— $197,240 
Investment securities - fair value
Sponsored funds77,433 — — 77,433 
Equity securities19,871 — — 19,871 
Nonqualified retirement plan assets12,682 — — 12,682 
Total assets measured at fair value$307,226 $ $ $307,226 
Liabilities
Contingent consideration$— $— $56,200 $56,200 
Total liabilities measured at fair value$ $ $56,200 $56,200 
The assets and liabilities of CIP measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
As of March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$119,914 $— $— $119,914 
Debt investments— 2,003,579 47,551 2,051,130 
Equity investments 29,469 384 242 30,095 
Total assets measured at fair value$149,383 $2,003,963 $47,793 $2,201,139 
Liabilities
Notes payable$— $1,922,051 $— $1,922,051 
Short sales485 — — 485 
Total liabilities measured at fair value$485 $1,922,051 $ $1,922,536 
As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$98,101 $— $— $98,101 
Debt investments241 2,012,760 36,616 2,049,617 
Equity investments32,642 446 33,096 
Total assets measured at fair value$130,984 $2,012,768 $37,062 $2,180,814 
Liabilities
Notes payable$— $1,922,243 $— $1,922,243 
Short sales518 — — 518 
Total liabilities measured at fair value$518 $1,922,243 $ $1,922,761 
Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value
The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:
Three Months Ended
March 31,
(in thousands)20242023
Contingent consideration, beginning of period$56,200 $78,100 
Reduction for payments made(14,492)(16,390)
Contingent consideration, end of period$41,708 $61,710 
v3.24.1.u1
Accumulated Other Comprehensive Income (Loss) (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive income (loss) were as follows:
Three Months Ended
March 31,
(in thousands)20242023
Balance at beginning of period$(87)$(358)
Net current-period other comprehensive income (loss) (1)(100)99 
Balance at end of period$(187)$(259)
(1)     Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively.
v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Expense
Stock-based compensation expense is summarized as follows:
Three Months Ended March 31,
(in thousands)20242023
Stock-based compensation expense$6,831 $5,749 
Schedule of Restricted Stock Units Activity
RSU activity, inclusive of PSUs, for the three months ended March 31, 2024 is summarized as follows: 
Number
of Shares
Weighted Average
Grant Date
Fair Value
Outstanding at December 31, 2023344,717 $204.48 
Granted108,658 $235.14 
Forfeited(8,333)$261.65 
Settled(103,849)$229.92 
Outstanding at March 31, 2024341,193 $205.10 
v3.24.1.u1
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The computation of basic and diluted EPS is as follows: 
 Three Months Ended March 31,
(in thousands, except per share amounts)20242023
Net Income (Loss)$37,867 $34,643 
Noncontrolling interests(8,009)3,981 
Net Income (Loss) Attributable to Virtus Investment Partners, Inc.$29,858 $38,624 
Shares:
Basic: Weighted-average number of shares outstanding7,119 7,245 
Plus: Incremental shares from assumed conversion of dilutive instruments168 165 
Diluted: Weighted-average number of shares outstanding7,287 7,410 
Earnings (Loss) per Share—Basic$4.19 $5.33 
Earnings (Loss) per Share—Diluted$4.10 $5.21 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.
 Three Months Ended March 31,
(in thousands)20242023
Restricted stock units40 
Total anti-dilutive securities1 40 
v3.24.1.u1
Redeemable Noncontrolling Interests (Tables)
3 Months Ended
Mar. 31, 2024
Noncontrolling Interest [Abstract]  
Schedule of Redeemable Noncontrolling Interest
Redeemable noncontrolling interests for the three months ended March 31, 2024 included the following amounts:
(in thousands)CIPAffiliate Noncontrolling InterestsTotal
Balances at December 31, 2023$30,643 $74,226 $104,869 
Net income (loss) attributable to noncontrolling interests1,429 1,829 3,258 
Changes in redemption value (1)— 4,360 4,360 
Total net income (loss) attributable to noncontrolling interests1,429 6,189 7,618 
Affiliate equity sales (purchases)— (419)(419)
Net subscriptions (redemptions) and other3,117 — 3,117 
Balances at March 31, 2024$35,189 $79,996 $115,185 
(1)     Relates to noncontrolling interests redeemable at other than fair value.
v3.24.1.u1
Consolidation (Tables)
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Condensed Consolidated Balance Sheets
The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023:
As of
 March 31, 2024December 31, 2023
VOEsVIEsVOEsVIEs
(in thousands)CLOs GFsCLOsGFs
Cash and cash equivalents$1,271 $119,914 $2,612 $1,223 $98,101 $2,088 
Investments40,591 1,962,697 77,937 30,985 1,972,342 79,386 
Other assets616 30,064 1,168 174 41,985 1,076 
Notes payable— (1,922,051)— — (1,922,243)— 
Securities purchased payable and other liabilities(1,019)(88,270)(1,999)(740)(89,167)(616)
Noncontrolling interests(12,311)(4,351)(22,878)(7,316)(4,363)(23,327)
Net interests in CIP$29,148 $98,003 $56,840 $24,326 $96,655 $58,607 
Schedule of VIE Consolidated Investment Product Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, Consolidation (Topic 810) ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March 31, 2024, as shown in the table below:
(in thousands)
Subordinated notes$96,416 
Accrued investment management fees1,587 
Total Beneficial Interests$98,003 
The following table represents income and expenses of the consolidated CLOs included on the Company’s Condensed Consolidated Statements of Operations for the period indicated:
Three Months Ended March 31, 2024
(in thousands)
Income:
Realized and unrealized gain (loss), net$
Interest income49,280 
Total Income49,281 
Expenses:
Other operating expenses499 
Interest expense40,011 
Total Expense40,510 
Noncontrolling interests(391)
Net Income (Loss) Attributable to CLOs$8,380 

The following table represents the Company’s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:
Three Months Ended March 31, 2024
(in thousands)
Distributions received and unrealized gains (losses) on the subordinated notes held by the Company$6,083 
Investment management fees2,297 
Total Economic Interests$8,380 
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
March 31, 2024  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$92,458 $— $— $92,458 
Investment securities - fair value
Sponsored funds69,514 — — 69,514 
Equity securities20,983 — — 20,983 
Nonqualified retirement plan assets13,743 — — 13,743 
Total assets measured at fair value$196,698 $ $ $196,698 
Liabilities
Contingent consideration$— $— $41,708 $41,708 
Total liabilities measured at fair value$ $ $41,708 $41,708 
December 31, 2023  
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$197,240 $— $— $197,240 
Investment securities - fair value
Sponsored funds77,433 — — 77,433 
Equity securities19,871 — — 19,871 
Nonqualified retirement plan assets12,682 — — 12,682 
Total assets measured at fair value$307,226 $ $ $307,226 
Liabilities
Contingent consideration$— $— $56,200 $56,200 
Total liabilities measured at fair value$ $ $56,200 $56,200 
The assets and liabilities of CIP measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 by fair value hierarchy level were as follows:
As of March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$119,914 $— $— $119,914 
Debt investments— 2,003,579 47,551 2,051,130 
Equity investments 29,469 384 242 30,095 
Total assets measured at fair value$149,383 $2,003,963 $47,793 $2,201,139 
Liabilities
Notes payable$— $1,922,051 $— $1,922,051 
Short sales485 — — 485 
Total liabilities measured at fair value$485 $1,922,051 $ $1,922,536 
As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents$98,101 $— $— $98,101 
Debt investments241 2,012,760 36,616 2,049,617 
Equity investments32,642 446 33,096 
Total assets measured at fair value$130,984 $2,012,768 $37,062 $2,180,814 
Liabilities
Notes payable$— $1,922,243 $— $1,922,243 
Short sales518 — — 518 
Total liabilities measured at fair value$518 $1,922,243 $ $1,922,761 
Schedule of Reconciliation of Assets of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value
The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:
 Three Months Ended March 31,
 (in thousands)
20242023
Balance at beginning of period$37,062 $43,581 
Realized and unrealized gains (losses), net(324)111 
Purchases— 
Sales(14,625)(7,195)
Transfers to Level 2(13,468)(35,747)
Transfers from Level 239,148 9,904 
Balance at end of period (1)$47,793 $10,658 
(1)The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment. Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.
v3.24.1.u1
Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Revenues $ 222,042 $ 197,874
Investment management fees    
Disaggregation of Revenue [Line Items]    
Revenues 188,360 164,478
Open-end funds    
Disaggregation of Revenue [Line Items]    
Revenues 78,680 71,266
Closed-end funds    
Disaggregation of Revenue [Line Items]    
Revenues 14,394 14,678
Retail separate accounts    
Disaggregation of Revenue [Line Items]    
Revenues 48,981 40,079
Institutional accounts    
Disaggregation of Revenue [Line Items]    
Revenues $ 46,305 $ 38,455
v3.24.1.u1
Acquisitions (Details) - USD ($)
$ in Thousands
Apr. 01, 2023
Mar. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]      
Goodwill   $ 397,098 $ 397,098
AlphaSimplex Group, LLC      
Business Acquisition [Line Items]      
Purchase price $ 113,400    
Goodwill 48,300    
Definite-lived intangible assets acquired $ 55,400    
v3.24.1.u1
Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Definite-Lived  
Gross book value, beginning of period $ 806,655
Accumulated amortization, beginning of period (416,834)
Definite-Lived net book value, beginning of period 389,821
Intangible amortization (15,335)
Gross book value balance, end of period 806,655
Accumulated amortization, end of period (432,169)
Definite-Lived net book value, end of period 374,486
Indefinite-Lived  
Net book value, beginning of period 42,298
Net book value, end of period 42,298
Total  
Net book value, beginning of period 432,119
Intangible amortization (15,335)
Net book value, end of period $ 416,784
v3.24.1.u1
Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Remainder of 2024 $ 40,964  
2025 51,532  
2026 50,552  
2027 47,450  
2028 41,787  
2029 and thereafter 142,201  
Total $ 374,486 $ 389,821
v3.24.1.u1
Investments - Investments (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Investments [Line Items]    
Investment securities - fair value $ 90,497 $ 97,304
Parent    
Schedule of Investments [Line Items]    
Investment securities - fair value 90,497 97,304
Equity method investments 23,208 22,710
Nonqualified retirement plan assets 13,743 12,682
Total investments $ 127,448 $ 132,696
v3.24.1.u1
Investments - Marketable Securities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Investment Securities - fair value    
Cost $ 85,942 $ 97,147
Fair Value 90,497 97,304
Sponsored funds    
Investment Securities - fair value    
Cost 69,067 80,794
Fair Value 69,514 77,433
Equity securities    
Investment Securities - fair value    
Cost 16,875 16,353
Fair Value $ 20,983 $ 19,871
v3.24.1.u1
Investments - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Investments [Abstract]    
Realized (losses) gains on trading securities $ (0.4) $ 1.3
v3.24.1.u1
Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash equivalents $ 92,458 $ 197,240
Investment securities - fair value    
Fair Value 90,497 97,304
Total assets measured at fair value 196,698 307,226
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Contingent consideration    
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Sponsored funds    
Investment securities - fair value    
Fair Value 69,514 77,433
Equity securities    
Investment securities - fair value    
Fair Value 20,983 19,871
Nonqualified retirement plan assets    
Investment securities - fair value    
Nonqualified retirement plan assets 13,743 12,682
Level 1    
Assets    
Cash equivalents 92,458 197,240
Investment securities - fair value    
Total assets measured at fair value 196,698 307,226
Liabilities    
Total liabilities measured at fair value 0 0
Level 1 | Contingent consideration    
Liabilities    
Total liabilities measured at fair value 0 0
Level 1 | Sponsored funds    
Investment securities - fair value    
Fair Value 69,514 77,433
Level 1 | Equity securities    
Investment securities - fair value    
Fair Value 20,983 19,871
Level 1 | Nonqualified retirement plan assets    
Investment securities - fair value    
Nonqualified retirement plan assets 13,743 12,682
Level 2    
Assets    
Cash equivalents 0 0
Investment securities - fair value    
Total assets measured at fair value 0 0
Liabilities    
Total liabilities measured at fair value 0 0
Level 2 | Contingent consideration    
Liabilities    
Total liabilities measured at fair value 0 0
Level 2 | Sponsored funds    
Investment securities - fair value    
Fair Value 0 0
Level 2 | Equity securities    
Investment securities - fair value    
Fair Value 0 0
Level 2 | Nonqualified retirement plan assets    
Investment securities - fair value    
Nonqualified retirement plan assets 0 0
Level 3    
Assets    
Cash equivalents 0 0
Investment securities - fair value    
Total assets measured at fair value 0 0
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Level 3 | Contingent consideration    
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Level 3 | Sponsored funds    
Investment securities - fair value    
Fair Value 0 0
Level 3 | Equity securities    
Investment securities - fair value    
Fair Value 0 0
Level 3 | Nonqualified retirement plan assets    
Investment securities - fair value    
Nonqualified retirement plan assets $ 0 $ 0
v3.24.1.u1
Fair Value Measurements - Narrative (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contingent consideration $ 66,704 $ 90,938
Westchester | Measurement Input, Comparability Adjustment    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.09  
Westchester | Minimum | Measurement Input, Discount Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.06  
Westchester | Maximum | Measurement Input, Discount Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.07  
Westchester | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contingent consideration $ 11,100  
NFJ Investment Group | Measurement Input, Comparability Adjustment    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.07  
NFJ Investment Group | Minimum | Measurement Input, Discount Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.06  
NFJ Investment Group | Maximum | Measurement Input, Discount Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, contingent consideration, liability, measurement input 0.07  
NFJ Investment Group | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contingent consideration $ 30,600  
v3.24.1.u1
Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details) - Level 3 - Contingent consideration - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent consideration, beginning of period $ 56,200 $ 78,100
Reduction for payments made (14,492) (16,390)
Contingent consideration, end of period $ 41,708 $ 61,710
v3.24.1.u1
Equity Transactions (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Feb. 21, 2024
Mar. 31, 2024
Mar. 31, 2023
Equity [Abstract]      
Cash dividends declared per common share (in dollars per share) $ 1.90 $ 1.90 $ 1.65
Stock repurchased during period, shares   21,108  
Weighted average price (in dollars per share)   $ 236.84  
Stock repurchased during period, value   $ 5.0  
Shares available for repurchase (in shares)   583,437  
v3.24.1.u1
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance at beginning of period $ 868,289 $ 822,936
Net current-period other comprehensive income (loss) (100) 99
Balance at end of period 876,003 844,297
Accumulated Foreign Currency Adjustment Attributable to Parent    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance at beginning of period (87) (358)
Net current-period other comprehensive income (loss) (100) 99
Balance at end of period (187) (259)
Other comprehensive income (loss), before reclassifications, tax $ 36 $ (35)
v3.24.1.u1
Stock-Based Compensation - Additional Information (Details)
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2023
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares of common stock available for issuance (in shares) 375,169  
Shares of common stock reserved for issuance (in shares) 3,370,000  
RSUs and PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unamortized stock-based compensation expense | $ $ 45.5  
Weighted-average remaining amortization period 1 year 7 months 6 days  
Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share settlement under RSUs (in shares) 42,588 70,716
Cash used for employee withholding tax payments | $ $ 9.9 $ 12.2
Restricted stock units (RSUs), performance-based    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Awards granted (in shares) 26,733 44,291
Performance Stock Units, Incentive    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Period for recognition of compensation expense 3 years  
Minimum | Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 1 year  
Maximum | Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 3 years  
Common Stock | Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Conversion ratio 1  
v3.24.1.u1
Stock-Based Compensation - Stock Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Stock-based compensation expense $ 6,831 $ 5,749
v3.24.1.u1
Stock-Based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs)
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Number of Shares  
Number of shares, outstanding (in shares) | shares 344,717
Number of shares, granted (in shares) | shares 108,658
Number of shares, forfeited (in shares) | shares (8,333)
Number of shares, settled (in shares) | shares (103,849)
Number of shares, outstanding (in shares) | shares 341,193
Weighted Average Grant Date Fair Value  
Weighted average grant date fair value, outstanding (in dollars per share) | $ / shares $ 204.48
Weighted-average grant-date fair value (in dollars per share) | $ / shares 235.14
Weighted average grant date fair value, forfeited (in dollars per share) | $ / shares 261.65
Weighted average grant date fair value, settled (in dollars per share) | $ / shares 229.92
Weighted average grant date fair value, outstanding (in dollars per share) | $ / shares $ 205.10
v3.24.1.u1
Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net Income (Loss) $ 37,867 $ 34,643
Noncontrolling interests (8,009) 3,981
Net Income (Loss) Attributable to Virtus Investment Partners, Inc. $ 29,858 $ 38,624
Shares:    
Basic: Weighted-average number of shares outstanding (in shares) 7,119 7,245
Plus: Incremental shares from assumed conversion of dilutive instruments (in shares) 168 165
Diluted: Weighted-average number of shares outstanding (in shares) 7,287 7,410
Earnings (Loss) per Share—Basic (in dollars per share) $ 4.19 $ 5.33
Earnings (Loss) per Share—Diluted (in dollars per share) $ 4.10 $ 5.21
v3.24.1.u1
Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive securities (in shares) 1 40
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive securities (in shares) 1 40
v3.24.1.u1
Income Taxes (Details)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Estimated effective income tax rate (as percent) 18.90% 20.10%
v3.24.1.u1
Debt (Details) - USD ($)
3 Months Ended
Sep. 28, 2021
Mar. 31, 2024
Term loan | Secured Debt    
Line of Credit Facility [Line Items]    
Debt repayments   $ 700,000
Outstanding borrowings   258,100,000
Term loan | Credit Agreement    
Line of Credit Facility [Line Items]    
Maximum borrowing capacity $ 275,000,000  
Term of debt 7 years  
Term loan | Credit Facility 2017    
Line of Credit Facility [Line Items]    
Debt issuance costs   $ 5,100,000
Revolving credit facility | Credit Agreement    
Line of Credit Facility [Line Items]    
Maximum borrowing capacity $ 175,000,000  
Term of debt 5 years  
v3.24.1.u1
Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Balance at beginning of period $ 104,869  
Net income (loss) attributable to noncontrolling interests 3,258  
Changes in redemption value (13,624) $ (3,447)
Total net income (loss) attributable to noncontrolling interests 7,618 $ (4,746)
Affiliate equity sales (purchases) (419)  
Net subscriptions (redemptions) and other 3,117  
Balance at end of period 115,185  
CIP    
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Balance at beginning of period 30,643  
Net income (loss) attributable to noncontrolling interests 1,429  
Total net income (loss) attributable to noncontrolling interests 1,429  
Affiliate equity sales (purchases) 0  
Net subscriptions (redemptions) and other 3,117  
Balance at end of period 35,189  
Affiliate Noncontrolling Interests    
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Balance at beginning of period 74,226  
Net income (loss) attributable to noncontrolling interests 1,829  
Total net income (loss) attributable to noncontrolling interests 6,189  
Affiliate equity sales (purchases) (419)  
Net subscriptions (redemptions) and other 0  
Balance at end of period 79,996  
Portion at Other than Fair Value Measurement    
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Changes in redemption value 4,360  
Portion at Other than Fair Value Measurement | CIP    
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Changes in redemption value 0  
Portion at Other than Fair Value Measurement | Affiliate Noncontrolling Interests    
Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]    
Changes in redemption value $ 4,360  
v3.24.1.u1
Consolidation - Condensed Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Variable Interest Entity [Line Items]        
Noncontrolling interests $ (115,185) $ (104,869) $ (106,630) $ (113,718)
VOEs        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 1,271 1,223    
Investments 40,591 30,985    
Other assets 616 174    
Notes payable 0 0    
Securities purchased payable and other liabilities (1,019) (740)    
Noncontrolling interests (12,311) (7,316)    
Net interests in CIP 29,148 24,326    
CLOs        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 119,914 98,101    
Investments 1,962,697 1,972,342    
Other assets 30,064 41,985    
Notes payable (1,922,051) (1,922,243)    
Securities purchased payable and other liabilities (88,270) (89,167)    
Noncontrolling interests (4,351) (4,363)    
Net interests in CIP 98,003 96,655    
GFs        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 2,612 2,088    
Investments 77,937 79,386    
Other assets 1,168 1,076    
Notes payable 0 0    
Securities purchased payable and other liabilities (1,999) (616)    
Noncontrolling interests (22,878) (23,327)    
Net interests in CIP $ 56,840 $ 58,607    
v3.24.1.u1
Consolidation - Additional Information (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
collateralized_loan_obligation
Dec. 31, 2023
USD ($)
CLOs    
Variable Interest Entity [Line Items]    
Number of consolidated CLOs | collateralized_loan_obligation 7  
Investments $ 1,962,697 $ 1,972,342
CLOs | CLO subordinated notes    
Variable Interest Entity [Line Items]    
Debt par value 2,100,000  
CLOs | Senior Notes | CLO senior secured floating rate notes    
Variable Interest Entity [Line Items]    
Debt par value 1,900,000  
CLOs | Subordinated Debt | CLO subordinated notes    
Variable Interest Entity [Line Items]    
Debt par value 215,100  
Nonconsolidated VIEs    
Variable Interest Entity [Line Items]    
Carrying value and maximum risk of loss $ 29,100  
v3.24.1.u1
Consolidation - Beneficial Interests of Consolidated Investment Product (Details) - CLOs
$ in Thousands
Mar. 31, 2024
USD ($)
Variable Interest Entity [Line Items]  
Subordinated notes $ 96,416
Accrued investment management fees 1,587
Total Beneficial Interests $ 98,003
v3.24.1.u1
Consolidation - Revenue and Expenses of Consolidated Investment Product (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Expenses:    
Noncontrolling interests $ (8,009) $ 3,981
Net Income (Loss) Attributable to Virtus Investment Partners, Inc. 29,858 $ 38,624
CLOs    
Income:    
Realized and unrealized gain (loss), net 1  
Interest income 49,280  
Total Income 49,281  
Expenses:    
Other operating expenses 499  
Interest expense 40,011  
Total Expense 40,510  
Noncontrolling interests (391)  
Net Income (Loss) Attributable to Virtus Investment Partners, Inc. $ 8,380  
v3.24.1.u1
Consolidation - Economic Interests of Consolidated Investment Product (Details) - CLOs
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Variable Interest Entity [Line Items]  
Distributions received and unrealized gains (losses) on the subordinated notes held by the Company $ 6,083
Investment management fees 2,297
Total Economic Interests $ 8,380
v3.24.1.u1
Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash equivalents $ 92,458 $ 197,240
Total assets measured at fair value 196,698 307,226
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Level 1    
Assets    
Cash equivalents 92,458 197,240
Total assets measured at fair value 196,698 307,226
Liabilities    
Total liabilities measured at fair value 0 0
Level 2    
Assets    
Cash equivalents 0 0
Total assets measured at fair value 0 0
Liabilities    
Total liabilities measured at fair value 0 0
Level 3    
Assets    
Cash equivalents 0 0
Total assets measured at fair value 0 0
Liabilities    
Total liabilities measured at fair value 41,708 56,200
Fair Value, Measurements, Recurring | Consolidated Investment Products    
Assets    
Cash equivalents 119,914 98,101
Total assets measured at fair value 2,201,139 2,180,814
Liabilities    
Notes payable 1,922,051 1,922,243
Short sales 485 518
Total liabilities measured at fair value 1,922,536 1,922,761
Fair Value, Measurements, Recurring | Debt investments | Consolidated Investment Products    
Assets    
Investments 2,051,130 2,049,617
Fair Value, Measurements, Recurring | Equity investments | Consolidated Investment Products    
Assets    
Investments 30,095 33,096
Fair Value, Measurements, Recurring | Level 1 | Consolidated Investment Products    
Assets    
Cash equivalents 119,914 98,101
Total assets measured at fair value 149,383 130,984
Liabilities    
Notes payable 0 0
Short sales 485 518
Total liabilities measured at fair value 485 518
Fair Value, Measurements, Recurring | Level 1 | Debt investments | Consolidated Investment Products    
Assets    
Investments 0 241
Fair Value, Measurements, Recurring | Level 1 | Equity investments | Consolidated Investment Products    
Assets    
Investments 29,469 32,642
Fair Value, Measurements, Recurring | Level 2 | Consolidated Investment Products    
Assets    
Cash equivalents 0 0
Total assets measured at fair value 2,003,963 2,012,768
Liabilities    
Notes payable 1,922,051 1,922,243
Short sales 0 0
Total liabilities measured at fair value 1,922,051 1,922,243
Fair Value, Measurements, Recurring | Level 2 | Debt investments | Consolidated Investment Products    
Assets    
Investments 2,003,579 2,012,760
Fair Value, Measurements, Recurring | Level 2 | Equity investments | Consolidated Investment Products    
Assets    
Investments 384 8
Fair Value, Measurements, Recurring | Level 3 | Consolidated Investment Products    
Assets    
Cash equivalents 0 0
Total assets measured at fair value 47,793 37,062
Liabilities    
Notes payable 0 0
Short sales 0 0
Total liabilities measured at fair value 0 0
Fair Value, Measurements, Recurring | Level 3 | Debt investments | Consolidated Investment Products    
Assets    
Investments 47,551 36,616
Fair Value, Measurements, Recurring | Level 3 | Equity investments | Consolidated Investment Products    
Assets    
Investments $ 242 $ 446
v3.24.1.u1
Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details) - Debt investments - Consolidated Investment Products - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Assets    
Balance at beginning of period $ 37,062 $ 43,581
Realized and unrealized gain (loss) on investments, net (324) 111
Purchases 0 4
Sales (14,625) (7,195)
Transfers to Level 2 (13,468) (35,747)
Transfers from Level 2 39,148 9,904
Balance at end of period $ 47,793 $ 10,658

Grafico Azioni Virtus Investment Partners (NYSE:VRTS)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Virtus Investment Partners
Grafico Azioni Virtus Investment Partners (NYSE:VRTS)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Virtus Investment Partners